Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	bisphosphoglycerate mutase activity	PGAM1 PGAM2 PGAM4	3.06e-06	4	184	3	GO:0004082
GeneOntologyMolecularFunction	2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity	PGAM1 PGAM2 PGAM4	3.06e-06	4	184	3	GO:0046538
GeneOntologyMolecularFunction	phosphoglycerate mutase activity	PGAM1 PGAM2 PGAM4	3.06e-06	4	184	3	GO:0004619
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate phosphatase activity	SACM1L SYNJ1 SYNJ2 MTMR2	6.50e-06	14	184	4	GO:0004438
GeneOntologyMolecularFunction	phosphatidylinositol monophosphate phosphatase activity	SACM1L SYNJ1 SYNJ2 MTMR2	8.80e-06	15	184	4	GO:0052744
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	SACM1L SYNJ1 SYNJ2 MTMR2	1.16e-05	16	184	4	GO:0106018
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	PLBD1 AARS1 MBLAC2 INPP1 POLD1 DUSP14 PPM1M ANKLE1 SACM1L FASN SYNJ1 SYNJ2 NYNRIN PAFAH2 MTMR2 PDE5A N4BP1 PLA2G4F RPE65 MGME1 SMG6	1.83e-05	807	184	21	GO:0016788
GeneOntologyMolecularFunction	phosphatidylinositol phosphate 4-phosphatase activity	SACM1L SYNJ1 SYNJ2	8.81e-05	10	184	3	GO:0034596
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate phosphatase activity	SACM1L SYNJ1 SYNJ2 MTMR2	1.04e-04	27	184	4	GO:0034593
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity	SYNJ1 SYNJ2 MTMR2	1.20e-04	11	184	3	GO:0052629
GeneOntologyMolecularFunction	intramolecular phosphotransferase activity	PGAM1 PGAM2 PGAM4	1.20e-04	11	184	3	GO:0016868
GeneOntologyMolecularFunction	phosphatidylinositol phosphate phosphatase activity	SACM1L SYNJ1 SYNJ2 MTMR2	1.59e-04	30	184	4	GO:0052866
GeneOntologyMolecularFunction	inositol trisphosphate phosphatase activity	INPP1 SYNJ1 SYNJ2	2.60e-04	14	184	3	GO:0046030
GeneOntologyMolecularFunction	extracellular matrix structural constituent	HSPG2 MXRA5 VWF LAMA5 LAMB3 THBS3 THBS4 LTBP2	3.63e-04	188	184	8	GO:0005201
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 DNAH3 TRIM58 DNAH2	3.63e-04	37	184	4	GO:0045505
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	VLDLR STAB1 LRP2	3.95e-04	16	184	3	GO:0005041
GeneOntologyMolecularFunction	cell adhesion molecule binding	NPHS1 LILRA2 VWF LAMA5 AHSA1 ITGAX ITGB4 TENM2 FASN THBS4 NEO1 TENM3 ICAM5 NOS3 PALLD	4.53e-04	599	184	15	GO:0050839
GeneOntologyMolecularFunction	phosphatidylinositol-4-phosphate phosphatase activity	SACM1L SYNJ1	5.01e-04	4	184	2	GO:0043812
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH3 DNAH2	5.67e-04	18	184	3	GO:0008569
GeneOntologyMolecularFunction	inositol phosphate phosphatase activity	INPP1 SYNJ1 SYNJ2	7.82e-04	20	184	3	GO:0052745
GeneOntologyMolecularFunction	very-low-density lipoprotein particle binding	VLDLR PLTP	8.29e-04	5	184	2	GO:0034189
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	VLDLR STAB1 LRP2	9.06e-04	21	184	3	GO:0030228
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	AARS1 SGIP1 POLD1 DDX60 POLR3H ANKLE1 INO80 SRCAP TEP1 CRY2 DIMT1 NYNRIN N4BP1 MGME1 SMG6	9.64e-04	645	184	15	GO:0140640
GeneOntologyMolecularFunction	microfibril binding	ADAMTSL5 LTBP2	1.24e-03	6	184	2	GO:0050436
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity	SYNJ1 SYNJ2	1.24e-03	6	184	2	GO:0043813
GeneOntologyBiologicalProcess	phosphatidylinositol dephosphorylation	SACM1L SYNJ1 SYNJ2 MTMR2 MTMR9	6.36e-06	30	184	5	GO:0046856
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH3 DNAH2	7.57e-05	10	183	3	GO:0036156
GeneOntologyCellularComponent	basement membrane	NPHS1 HSPG2 LAMA5 LAMB3 ITGB4 THBS4 USH2A	1.01e-04	122	183	7	GO:0005604
GeneOntologyCellularComponent	collagen-containing extracellular matrix	NPHS1 HSPG2 MXRA5 VWF COL20A1 LAMA5 LAMB3 ITGB4 THBS3 THBS4 ADAMTSL5 LTBP2 ANXA9 USH2A	2.49e-04	530	183	14	GO:0062023
GeneOntologyCellularComponent	9+2 motile cilium	DNHD1 DNAH3 DNAH2 ACE PGAM1 TTLL8 CFAP65 PGAM4 SLIRP	2.58e-04	238	183	9	GO:0097729
GeneOntologyCellularComponent	laminin-5 complex	LAMA5 LAMB3	4.52e-04	4	183	2	GO:0005610
GeneOntologyCellularComponent	sperm flagellum	DNHD1 DNAH2 ACE PGAM1 TTLL8 CFAP65 PGAM4 SLIRP	6.12e-04	214	183	8	GO:0036126
GeneOntologyCellularComponent	axonal growth cone	LIMK1 NEO1 LRP2 PALLD	6.40e-04	45	183	4	GO:0044295
MousePheno	abnormal epidermal-dermal junction morphology	LAMA5 LAMB3 ITGB4 TP63	5.74e-06	12	149	4	MP:0011159
Domain	Ig_I-set	NPHS1 HSPG2 IGFN1 SDK2 MXRA5 AXL ROR1 ISLR NEO1 ICAM5 CNTN3 PALLD ALPK2 ADGRA3	4.95e-09	190	181	14	IPR013098
Domain	I-set	NPHS1 HSPG2 IGFN1 SDK2 MXRA5 AXL ROR1 ISLR NEO1 ICAM5 CNTN3 PALLD ALPK2 ADGRA3	4.95e-09	190	181	14	PF07679
Domain	fn3	TRIM46 EPHB4 NPHS1 IGFN1 SDK2 COL20A1 AXL ITGB4 NEO1 CNTN3 USH2A IL27RA	6.06e-08	162	181	12	PF00041
Domain	IGc2	NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 ROR1 ISLR NEO1 ICAM5 CNTN3 FCRL5 PALLD ALPK2	7.32e-08	235	181	14	SM00408
Domain	Ig_sub2	NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 ROR1 ISLR NEO1 ICAM5 CNTN3 FCRL5 PALLD ALPK2	7.32e-08	235	181	14	IPR003598
Domain	EGF_1	HSPG2 VLDLR LAMA5 LAMB3 ITGB4 TENM2 STAB1 MEP1B THBS3 THBS4 TENM3 LRP2 LTBP2 USH2A	2.00e-07	255	181	14	PS00022
Domain	FN3	TRIM46 EPHB4 NPHS1 IGFN1 SDK2 COL20A1 AXL ITGB4 NEO1 CNTN3 USH2A IL27RA	2.59e-07	185	181	12	SM00060
Domain	EGF-like_CS	EPHB4 HSPG2 VLDLR LAMA5 LAMB3 ITGB4 TENM2 STAB1 MEP1B THBS3 THBS4 TENM3 LRP2 LTBP2	2.66e-07	261	181	14	IPR013032
Domain	EGF_2	EPHB4 HSPG2 VLDLR LAMA5 LAMB3 ITGB4 TENM2 STAB1 MEP1B THBS3 THBS4 TENM3 LRP2 LTBP2	3.20e-07	265	181	14	PS01186
Domain	Ig-like_fold	TRIM46 EPHB4 NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 HLA-DMA COL20A1 AXL ROR1 ISLR ITGB4 NEO1 ICAM5 CNTN3 FCRL5 USH2A PALLD ALPK2 ADGRA3 IL27RA	3.67e-07	706	181	23	IPR013783
Domain	-	TRIM46 EPHB4 NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 COL20A1 AXL ROR1 ISLR ITGB4 NEO1 ICAM5 CNTN3 FCRL5 USH2A PALLD ALPK2 ADGRA3 IL27RA	4.95e-07	663	181	22	2.60.40.10
Domain	FN3	TRIM46 EPHB4 NPHS1 IGFN1 SDK2 COL20A1 AXL ITGB4 NEO1 CNTN3 USH2A IL27RA	5.67e-07	199	181	12	PS50853
Domain	FN3_dom	TRIM46 EPHB4 NPHS1 IGFN1 SDK2 COL20A1 AXL ITGB4 NEO1 CNTN3 USH2A IL27RA	9.55e-07	209	181	12	IPR003961
Domain	ConA-like_dom	TRIM46 HSPG2 TRIM58 COL20A1 LAMA5 TRIM65 ITGB4 MEP1B THBS3 THBS4 USH2A ALK	1.56e-06	219	181	12	IPR013320
Domain	Phosphogly_mut1	PGAM1 PGAM2 PGAM4	3.56e-06	4	181	3	IPR005952
Domain	IG_LIKE	NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 HLA-DMA AXL ROR1 ISLR NEO1 ICAM5 CNTN3 FCRL5 PALLD ALPK2 ADGRA3	6.11e-06	491	181	17	PS50835
Domain	Ig-like_dom	NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 HLA-DMA AXL ROR1 ISLR NEO1 ICAM5 CNTN3 FCRL5 PALLD ALPK2 ADGRA3	8.39e-06	503	181	17	IPR007110
Domain	Syja_N	SACM1L SYNJ1 SYNJ2	8.83e-06	5	181	3	PF02383
Domain	SAC	SACM1L SYNJ1 SYNJ2	8.83e-06	5	181	3	PS50275
Domain	SAC_dom	SACM1L SYNJ1 SYNJ2	8.83e-06	5	181	3	IPR002013
Domain	EGF_LAM_2	HSPG2 LAMA5 LAMB3 STAB1 USH2A	9.47e-06	30	181	5	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA5 LAMB3 STAB1 USH2A	9.47e-06	30	181	5	PS01248
Domain	IG	NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 AXL ROR1 NEO1 ICAM5 CNTN3 FCRL5 PALLD ALPK2 ADGRA3	1.57e-05	421	181	15	SM00409
Domain	Ig_sub	NPHS1 HSPG2 LILRA2 IGFN1 SDK2 MXRA5 AXL ROR1 NEO1 ICAM5 CNTN3 FCRL5 PALLD ALPK2 ADGRA3	1.57e-05	421	181	15	IPR003599
Domain	ig	NPHS1 HSPG2 LILRA2 SDK2 HLA-DMA AXL ICAM5 CNTN3 FCRL5 ADGRA3	1.68e-05	190	181	10	PF00047
Domain	Immunoglobulin	NPHS1 HSPG2 LILRA2 SDK2 HLA-DMA AXL ICAM5 CNTN3 FCRL5 ADGRA3	1.68e-05	190	181	10	IPR013151
Domain	EGF	HSPG2 VLDLR LAMA5 TENM2 STAB1 MEP1B THBS3 THBS4 TENM3 LRP2 LTBP2	1.91e-05	235	181	11	SM00181
Domain	Laminin_G	HSPG2 COL20A1 LAMA5 THBS3 THBS4 USH2A	2.03e-05	58	181	6	IPR001791
Domain	EGF_Lam	HSPG2 LAMA5 LAMB3 STAB1 USH2A	2.07e-05	35	181	5	SM00180
Domain	Laminin_EGF	HSPG2 LAMA5 LAMB3 STAB1 USH2A	2.07e-05	35	181	5	PF00053
Domain	Growth_fac_rcpt_	EPHB4 HSPG2 VLDLR LAMA5 STAB1 THBS3 THBS4 LRP2 LTBP2	2.17e-05	156	181	9	IPR009030
Domain	EGF_CA	HSPG2 VLDLR TENM2 STAB1 THBS3 THBS4 LRP2 LTBP2	2.51e-05	122	181	8	SM00179
Domain	EGF-like_Ca-bd_dom	HSPG2 VLDLR TENM2 STAB1 THBS3 THBS4 LRP2 LTBP2	2.82e-05	124	181	8	IPR001881
Domain	Laminin_EGF	HSPG2 LAMA5 LAMB3 STAB1 USH2A	3.13e-05	38	181	5	IPR002049
Domain	EGF-like_dom	HSPG2 VLDLR LAMA5 TENM2 STAB1 MEP1B THBS3 THBS4 TENM3 LRP2 LTBP2	3.25e-05	249	181	11	IPR000742
Domain	PG/BPGM_mutase_AS	PGAM1 PGAM2 PGAM4	7.20e-05	9	181	3	IPR001345
Domain	6-blade_b-propeller_TolB-like	VLDLR TENM2 TENM3 WRAP73 LRP2	8.03e-05	46	181	5	IPR011042
Domain	DUF1866	SYNJ1 SYNJ2	9.34e-05	2	181	2	IPR015047
Domain	DUF1866	SYNJ1 SYNJ2	9.34e-05	2	181	2	PF08952
Domain	DUF1866	SYNJ1 SYNJ2	9.34e-05	2	181	2	SM01165
Domain	EGF_3	HSPG2 VLDLR TENM2 STAB1 MEP1B THBS3 THBS4 TENM3 LRP2 LTBP2	1.02e-04	235	181	10	PS50026
Domain	PGAM	PGAM1 PGAM2 PGAM4	1.02e-04	10	181	3	SM00855
Domain	PG_MUTASE	PGAM1 PGAM2 PGAM4	1.02e-04	10	181	3	PS00175
Domain	His_Pase_superF_clade-1	PGAM1 PGAM2 PGAM4	1.85e-04	12	181	3	IPR013078
Domain	His_Phos_1	PGAM1 PGAM2 PGAM4	1.85e-04	12	181	3	PF00300
Domain	EGF	HSPG2 VLDLR STAB1 MEP1B THBS4 LRP2 LTBP2	2.29e-04	126	181	7	PF00008
Domain	Rhs_assc_core	TENM2 TENM3	2.78e-04	3	181	2	IPR022385
Domain	COMP	THBS3 THBS4	2.78e-04	3	181	2	PF11598
Domain	Thbs/COMP_coiled-coil	THBS3 THBS4	2.78e-04	3	181	2	IPR024665
Domain	EGF_extracell	ITGB4 STAB1 TENM3 LRP2 LTBP2	2.87e-04	60	181	5	IPR013111
Domain	EGF_2	ITGB4 STAB1 TENM3 LRP2 LTBP2	2.87e-04	60	181	5	PF07974
Domain	Dynein_HC_stalk	DNHD1 DNAH3 DNAH2	3.01e-04	14	181	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH3 DNAH2	3.01e-04	14	181	3	IPR013602
Domain	DHC_N2	DNHD1 DNAH3 DNAH2	3.01e-04	14	181	3	PF08393
Domain	MT	DNHD1 DNAH3 DNAH2	3.01e-04	14	181	3	PF12777
Domain	DHC_fam	DNHD1 DNAH3 DNAH2	3.74e-04	15	181	3	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH3 DNAH2	3.74e-04	15	181	3	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH3 DNAH2	3.74e-04	15	181	3	IPR004273
Domain	Laminin_N	LAMA5 LAMB3 USH2A	4.57e-04	16	181	3	IPR008211
Domain	LamNT	LAMA5 LAMB3 USH2A	4.57e-04	16	181	3	SM00136
Domain	LAMININ_NTER	LAMA5 LAMB3 USH2A	4.57e-04	16	181	3	PS51117
Domain	Laminin_N	LAMA5 LAMB3 USH2A	4.57e-04	16	181	3	PF00055
Domain	-	VLDLR TENM2 TENM3 LRP2	5.38e-04	39	181	4	2.120.10.30
Domain	Tox-GHH_dom	TENM2 TENM3	5.53e-04	4	181	2	IPR028916
Domain	FAM47	FAM47C FAM47B	5.53e-04	4	181	2	PF14642
Domain	Tox-GHH	TENM2 TENM3	5.53e-04	4	181	2	PF15636
Domain	Ten_N	TENM2 TENM3	5.53e-04	4	181	2	IPR009471
Domain	Ten_N	TENM2 TENM3	5.53e-04	4	181	2	PF06484
Domain	FAM47	FAM47C FAM47B	5.53e-04	4	181	2	IPR032743
Domain	TENEURIN_N	TENM2 TENM3	5.53e-04	4	181	2	PS51361
Domain	Ig_2	HSPG2 LILRA2 NEO1 ICAM5 FCRL5	7.13e-04	73	181	5	PF13895
Domain	-	PGAM1 PGAM2 PGAM4	9.04e-04	20	181	3	3.40.50.1240
Domain	His_PPase_superfam	PGAM1 PGAM2 PGAM4	9.04e-04	20	181	3	IPR029033
Domain	TSP_3	THBS3 THBS4	9.16e-04	5	181	2	PF02412
Domain	TSP3	THBS3 THBS4	9.16e-04	5	181	2	PS51234
Domain	TSP_CTER	THBS3 THBS4	9.16e-04	5	181	2	PS51236
Domain	COUP_TF	NR2F1 NR2F2	9.16e-04	5	181	2	IPR003068
Domain	Thrombospondin_3_rpt	THBS3 THBS4	9.16e-04	5	181	2	IPR017897
Domain	YD	TENM2 TENM3	9.16e-04	5	181	2	IPR006530
Domain	TSP_type-3_rpt	THBS3 THBS4	9.16e-04	5	181	2	IPR028974
Domain	-	THBS3 THBS4	9.16e-04	5	181	2	4.10.1080.10
Domain	Thrombospondin_C	THBS3 THBS4	9.16e-04	5	181	2	IPR008859
Domain	TSP_C	THBS3 THBS4	9.16e-04	5	181	2	PF05735
Domain	Thrombospondin_3-like_rpt	THBS3 THBS4	9.16e-04	5	181	2	IPR003367
Domain	-	HSPG2 VLDLR LRP2 ALK	1.01e-03	46	181	4	4.10.400.10
Domain	LDLRA_1	HSPG2 VLDLR LRP2 ALK	1.19e-03	48	181	4	PS01209
Domain	LDrepeatLR_classA_rpt	HSPG2 VLDLR LRP2 ALK	1.29e-03	49	181	4	IPR002172
Domain	LDLa	HSPG2 VLDLR LRP2 ALK	1.29e-03	49	181	4	SM00192
Domain	LDLRA_2	HSPG2 VLDLR LRP2 ALK	1.29e-03	49	181	4	PS50068
Domain	TSPN	COL20A1 THBS3 THBS4	1.37e-03	23	181	3	SM00210
Domain	EGF_CA	VLDLR THBS3 THBS4 LRP2 LTBP2	1.49e-03	86	181	5	PF07645
Domain	Tyr_kinase_cat_dom	EPHB4 AXL ROR1 MAP3K9 ALK	1.66e-03	88	181	5	IPR020635
Domain	TyrKc	EPHB4 AXL ROR1 MAP3K9 ALK	1.66e-03	88	181	5	SM00219
Domain	RNase_Zc3h12a	NYNRIN N4BP1	1.90e-03	7	181	2	PF11977
Domain	RNase_Zc3h12_NYN	NYNRIN N4BP1	1.90e-03	7	181	2	IPR021869
Domain	Ser-Thr/Tyr_kinase_cat_dom	EPHB4 AXL ROR1 LIMK1 MAP3K9 ALK	2.28e-03	138	181	6	IPR001245
Domain	-	HSPG2 LAMA5 THBS3 THBS4 USH2A	2.32e-03	95	181	5	2.60.120.200
Domain	Kinase-like_dom	EPHB4 AXL ROR1 WDR81 LIMK1 UHMK1 MASTL MAP3K9 CDK1 IKBKB ALK ALPK2 SBK2	2.46e-03	542	181	13	IPR011009
Domain	WD40_repeat_dom	TAF1C WDR81 DYNC2I1 TEP1 WDR74 AAAS TENM3 SNRNP40 TLE6	2.50e-03	297	181	9	IPR017986
Domain	GAF	EFCAB5 PDE5A	2.52e-03	8	181	2	IPR003018
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	HSPG2 VWF LAMA5 LAMB3 ITGB4 THBS3 THBS4	2.15e-05	84	142	7	M7098
Pubmed	Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements.	DUX4L2 DUX4 DUX5 DUX3 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	8.79e-17	17	191	9	11245978
Pubmed	Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element.	DUX4L9 DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	3.47e-16	12	191	8	10433963
Pubmed	Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy.	DUX4L9 DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	8.97e-16	13	191	8	17668377
Pubmed	The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein.	DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	1.07e-15	8	191	7	17588759
Pubmed	DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.	DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	1.60e-14	10	191	7	17984056
Pubmed	Characterization of a tandemly repeated 3.3-kb KpnI unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35.	DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	2.25e-13	13	191	7	7739628
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPHB4 HSPG2 EPPK1 CTC1 RNPEPL1 LAMA5 LAMB3 ANKLE1 INO80 SRCAP IDUA TEP1 ITGB4 NR2F2 NCOR1 FASN ADAMTSL5 SYNJ1 MTHFR NAPRT CPSF1 MBD5 TTC5 CABIN1 SOWAHB SMG6	4.83e-10	1105	191	26	35748872
Pubmed	Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis.	PGAM1 PGAM2 PGAM4	1.63e-07	3	191	3	32634742
Pubmed	Characterization of genetically modified mice for phosphoglycerate mutase, a vitally-essential enzyme in glycolysis.	PGAM1 PGAM2 PGAM4	1.63e-07	3	191	3	33914812
Pubmed	Developmental activation of phosphoglycerate mutase-2 in the testis of the mouse.	PGAM1 PGAM2 PGAM4	1.63e-07	3	191	3	2824255
Pubmed	Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping.	PGAM1 PGAM2 PGAM4	1.63e-07	3	191	3	11250083
Pubmed	Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke.	ACE MTHFR NOS3	1.63e-07	3	191	3	15595935
Pubmed	Deacetylation of phosphoglycerate mutase in its distinct central region by SIRT2 down-regulates its enzymatic activity.	PGAM1 PGAM2 PGAM4	6.50e-07	4	191	3	25195573
Pubmed	The homeobox transcription factor DUXBL controls exit from totipotency.	DUX4L9 DUX4L2 DUX4L4	6.50e-07	4	191	3	38509386
Pubmed	Expression profiling of immature thymocytes revealed a novel homeobox gene that regulates double-negative thymocyte development.	DUX4L9 DUX4L2 DUX4L4	6.50e-07	4	191	3	17911620
Pubmed	Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.	VWF DUOX2 ACE KCNA5 MTHFR PDE5A NOS3	9.23e-07	94	191	7	20346360
Pubmed	Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay?	ACE MTHFR NOS3	1.62e-06	5	191	3	19372095
Pubmed	Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease.	ACE MTHFR NOS3	1.62e-06	5	191	3	21450592
Pubmed	Genetic effects on carotid intima-media thickness: systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects.	ACE MTHFR NOS3	1.62e-06	5	191	3	20160191
Pubmed	Characterization of genomic structures and expression profiles of three tandem repeats of a mouse double homeobox gene: Duxbl.	DUX4L9 DUX4L2 DUX4L4	1.62e-06	5	191	3	20063414
Pubmed	Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis.	ACE MTHFR NOS3	3.22e-06	6	191	3	17920311
Pubmed	The estimation of gametic disequilibrium between DNA markers in candidate genes for coronary artery disease (CAD) and the associations of gene complexes with risk factors for CAD.	ACE MTHFR NOS3	3.22e-06	6	191	3	11507973
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	AARS1 EPPK1 LAMA5 LAMB3 AHSA1 PGAM1 PGAM2 ITGB4 SACM1L SFXN1 FASN SLC25A12 PGAM4 C3 SLIRP	3.31e-06	647	191	15	26618866
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	HSPG2 VWF LAMA5 LAMB3 THBS4 ADAMTSL5 LTBP2 ANXA9	4.29e-06	167	191	8	22159717
Pubmed	PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα.	HSPG2 LAMA5 LAMB3 ITGB4	4.90e-06	21	191	4	27856617
Pubmed	A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis.	ACE MTHFR NOS3	5.61e-06	7	191	3	19210273
Pubmed	CoupTFI interacts with retinoic acid signaling during cortical development.	NR2F1 NR2F2 TBR1	5.61e-06	7	191	3	23472160
Pubmed	[Analysis of gene complexes predisposing to coronary atherosclerosis].	ACE MTHFR NOS3	5.61e-06	7	191	3	11963567
Pubmed	The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection.	DUX4L9 DUX4L2 DUX4L4	5.61e-06	7	191	3	30765463
Pubmed	Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women.	ACE MTHFR NOS3	5.61e-06	7	191	3	12468767
Pubmed	Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.	ACE MTHFR NOS3	5.61e-06	7	191	3	15831156
Pubmed	Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients.	NPHS1 ACE MTHFR	5.61e-06	7	191	3	19520069
Pubmed	Variants of folate metabolism genes and risk of left-sided cardiac defects.	TCN2 MTHFR NOS3	8.95e-06	8	191	3	19777601
Pubmed	Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2.	PGAM1 PGAM2 PGAM4	8.95e-06	8	191	3	24567357
Pubmed	Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis.	LAMA5 LAMB3 ITGB4	8.95e-06	8	191	3	23529140
Pubmed	Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis.	EPHB4 VWF NR2F2	8.95e-06	8	191	3	19705428
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DNAH3 MXRA5 FXR2 ROR1 DNAH2 LAMB3 SFXN1 THBS4 LRP2 MAP3K9 CPSF1 CDK1 TBR1 RPE65 MTMR9	1.53e-05	736	191	15	29676528
Pubmed	Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: An application of tree-structured survival analysis.	ACE MTHFR NOS3	1.90e-05	10	191	3	16928730
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	VLDLR ROR1 ITGB4 LRP2 FCRL5 ALK	2.08e-05	101	191	6	23382219
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SDK2 COL20A1 DNAH2 TENM3 CNTN3 MBD5	2.33e-05	103	191	6	10819331
Pubmed	ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.	HSPG2 LAMA5 ITGB4 TP63	2.47e-05	31	191	4	22274697
Pubmed	Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity.	EPHB4 VWF NR2F2	2.60e-05	11	191	3	15875024
Pubmed	Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival.	LAMA5 LAMB3 ITGB4	2.60e-05	11	191	3	8707838
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	HSPG2 AXL LAMA5 TEP1 FASN NEO1 SNRNP40 IKBKB	2.61e-05	214	191	8	22199357
Pubmed	Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy.	ACE NOS3	3.00e-05	2	191	2	25227524
Pubmed	cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.	PDE5A NOS3	3.00e-05	2	191	2	15576651
Pubmed	[Relationships between polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase genes and genetic susceptibility to pregnancy induced hypertension].	ACE MTHFR	3.00e-05	2	191	2	15312318
Pubmed	Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.	PDE5A NOS3	3.00e-05	2	191	2	23844149
Pubmed	The relationship between of ACE I/D and the MTHFR C677T polymorphisms in the pathophysiology of type 2 diabetes mellitus in a population of Brazilian obese patients.	ACE MTHFR	3.00e-05	2	191	2	29694640
Pubmed	The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain.	ITGAX C3	3.00e-05	2	191	2	7512600
Pubmed	The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with the level of decrease on diastolic blood pressure in essential hypertension patients treated by angiotensin-converting enzyme inhibitor.	ACE MTHFR	3.00e-05	2	191	2	15226090
Pubmed	Eph-B4 mediates vein graft adaptation by regulation of endothelial nitric oxide synthase.	EPHB4 NOS3	3.00e-05	2	191	2	26817610
Pubmed	A novel multiplex PCR-RFLP method for simultaneous detection of the MTHFR 677 C > T, eNOS +894 G > T and - eNOS -786 T > C variants among Malaysian Malays.	MTHFR NOS3	3.00e-05	2	191	2	22594584
Pubmed	The Synaptojanins in the murine small and large intestine.	SYNJ1 SYNJ2	3.00e-05	2	191	2	27878645
Pubmed	Genetic combination of angiotensin-converting enzyme with methylene tetrahydrofolate reductase polymorphisms and the risk of type 2 diabetes mellitus in Bahrain.	ACE MTHFR	3.00e-05	2	191	2	23447104
Pubmed	The junctional epithelium originates from the odontogenic epithelium of an erupted tooth.	LAMA5 ITGB4	3.00e-05	2	191	2	24785116
Pubmed	Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes.	MTHFR NOS3	3.00e-05	2	191	2	19330466
Pubmed	[Association between angiotensin-converting enzyme and polymorphisms of N5, N10-methylenetetrahydrofolic acid reductase gene in patients with ischemic stroke].	ACE MTHFR	3.00e-05	2	191	2	17633462
Pubmed	Genetic predisposition for development of nephropathy in type 2 diabetes mellitus.	ACE MTHFR	3.00e-05	2	191	2	23846111
Pubmed	Localization of transcripts of the related nuclear orphan receptors COUP-TF I and ARP-1 in the adult mouse brain.	NR2F1 NR2F2	3.00e-05	2	191	2	7609634
Pubmed	ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.	AXL ALK	3.00e-05	2	191	2	26616860
Pubmed	No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss.	MTHFR NOS3	3.00e-05	2	191	2	15214944
Pubmed	[GENES ALLELE STATUS OF ANGIOTENSINCONVERTING ENZYME (I/D) AND ENDOTHELIAL NITRIC OXIDE SYNTHASE (894 G > T) IN PATIENTS WITH ACUTE CORONARY SYNDROME].	ACE NOS3	3.00e-05	2	191	2	27089712
Pubmed	Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.	PDE5A NOS3	3.00e-05	2	191	2	21421555
Pubmed	ACE and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss.	ACE MTHFR	3.00e-05	2	191	2	18588608
Pubmed	[Polymorphism of genes coding for angiotensin I converting enzyme and methylenetetrahydrofolate reductase in patients with ischemic heart disease].	ACE MTHFR	3.00e-05	2	191	2	11712321
Pubmed	Combination of angiotensin-converting enzyme and methylenetetrahydrofolate reductase gene polymorphisms as determinant risk factors for chronic allograft dysfunction.	ACE MTHFR	3.00e-05	2	191	2	17275478
Pubmed	Lack of association between polymorphisms in angiotensin-converting-enzyme and methylenetetrahydrofolate reductase genes and normal cognitive ageing in humans.	ACE MTHFR	3.00e-05	2	191	2	12875914
Pubmed	Migraine and coronary artery disease: an open study on the genetic polymorphism of the 5, 10 methylenetetrahydrofolate (MTHFR) and angiotensin I-converting enzyme (ACE) genes.	ACE MTHFR	3.00e-05	2	191	2	20518725
Pubmed	Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran.	ACE MTHFR	3.00e-05	2	191	2	21942443
Pubmed	ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease.	ACE NOS3	3.00e-05	2	191	2	15498534
Pubmed	Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms.	ACE NOS3	3.00e-05	2	191	2	21844127
Pubmed	[The influence of single nucleotide polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme on the course of pregnancy complicated by type 1 diabetes].	ACE NOS3	3.00e-05	2	191	2	24505959
Pubmed	Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients.	TCN2 MTHFR	3.00e-05	2	191	2	12911562
Pubmed	An evolutionary conserved COUP-TF binding element in a neural-specific gene and COUP-TF expression patterns support a major role for COUP-TF in neural development.	NR2F1 NR2F2	3.00e-05	2	191	2	7708064
Pubmed	C677T methylentetrahydrofulate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer's disease in Iranian population.	ACE MTHFR	3.00e-05	2	191	2	16906459
Pubmed	Clinical Relevance of MTHFR, eNOS, ACE, and ApoE Gene Polymorphisms and Serum Vitamin Profile among Malay Patients with Ischemic Stroke.	MTHFR NOS3	3.00e-05	2	191	2	26187788
Pubmed	Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: Susceptibility and complications.	ACE MTHFR	3.00e-05	2	191	2	24452036
Pubmed	Association of Polymorphisms in Endothelial Nitric Oxide Synthesis and Renin-Angiotensin-Aldosterone System with Developing of Coronary Artery Disease in Bulgarian Patients.	ACE NOS3	3.00e-05	2	191	2	26670794
Pubmed	MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.	ACE MTHFR	3.00e-05	2	191	2	22554825
Pubmed	Spatiotemporal expression patterns of chicken ovalbumin upstream promoter-transcription factors in the developing mouse central nervous system: evidence for a role in segmental patterning of the diencephalon.	NR2F1 NR2F2	3.00e-05	2	191	2	8183930
Pubmed	Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.	TCN2 MTHFR	3.00e-05	2	191	2	18806228
Pubmed	Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population.	ACE MTHFR	3.00e-05	2	191	2	19081115
Pubmed	Dynamic expression of COUP-TFI and COUP-TFII during development and functional maturation of the mouse inner ear.	NR2F1 NR2F2	3.00e-05	2	191	2	15907456
Pubmed	Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation.	ACE NOS3	3.00e-05	2	191	2	12687832
Pubmed	Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.	ACE MTHFR	3.00e-05	2	191	2	15893594
Pubmed	Developmentally regulated alternative splicing in a novel synaptojanin.	SYNJ1 SYNJ2	3.00e-05	2	191	2	9442075
Pubmed	[Relations between endothelial nitric oxide synthase and angiotensin-converting gene polymorphisms and certain biochemical parameters in patients with cardiac syndrome X].	ACE NOS3	3.00e-05	2	191	2	15724677
Pubmed	Endothelial nitric oxide synthetase, methylenetetrahydrofolate reductase polymorphisms, and cardiovascular complications in Tunisian patients with nondiabetic renal disease.	MTHFR NOS3	3.00e-05	2	191	2	19376104
Pubmed	Gene network of a phosphoglycerate mutase in muscle wasting in mice.	PGAM1 PGAM4	3.00e-05	2	191	2	25644094
Pubmed	Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis.	ACE MTHFR	3.00e-05	2	191	2	26971290
Pubmed	Genetic susceptibility to atrial fibrillation in patients with congestive heart failure.	ACE NOS3	3.00e-05	2	191	2	16818212
Pubmed	Association of coronary artery disease with polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase gene.	ACE MTHFR	3.00e-05	2	191	2	19039150
Pubmed	Genetic predisposition to breath-hold diving-induced hemoptysis: Preliminary study.	ACE NOS3	3.00e-05	2	191	2	26094307
Pubmed	PGAM1 knockdown is associated with busulfan‑induced hypospermatogenesis and spermatogenic cell apoptosis.	PGAM1 PGAM4	3.00e-05	2	191	2	30720109
Pubmed	Evaluation of the roles of common genetic mutations in leukoaraiosis.	ACE MTHFR	3.00e-05	2	191	2	11696022
Pubmed	[Association between angiotensin-converting enzyme and endothelial nitric oxide synthase gene polymorphism and risk of coronary artery disease].	ACE NOS3	3.00e-05	2	191	2	18269824
Pubmed	Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk.	RCCD1 ANKLE1	3.00e-05	2	191	2	28362817
Pubmed	The Transcription Factors COUP-TFI and COUP-TFII have Distinct Roles in Arealisation and GABAergic Interneuron Specification in the Early Human Fetal Telencephalon.	NR2F1 NR2F2	3.00e-05	2	191	2	28922831
Pubmed	Methylenetetrahydrofolate reductase and angiotensin-converting enzyme gene polymorphisms among Saudi population from Qassim region.	ACE MTHFR	3.00e-05	2	191	2	19810824
Cytoband	4q35.2	DUX4L2 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	1.24e-09	27	189	6	4q35.2
Cytoband	Ensembl 112 genes in cytogenetic band chr4q35	DUX4L9 DUX4L2 DUX4 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	3.31e-08	117	189	8	chr4q35
Cytoband	8q24.3	EPPK1 ZNF707 NAPRT SHARPIN TIGD5	1.10e-04	113	189	5	8q24.3
Cytoband	2q24	SLC25A12 TBR1	9.05e-04	11	189	2	2q24
Cytoband	14q24	AHSA1 LTBP2	9.05e-04	11	189	2	14q24
GeneFamily	Fibronectin type III domain containing	EPHB4 NPHS1 IGFN1 SDK2 COL20A1 AXL ITGB4 NEO1 CNTN3 USH2A IL27RA	4.35e-08	160	139	11	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 IGFN1 SDK2 MXRA5 ROR1 ISLR NEO1 CNTN3 PALLD ALPK2 ADGRA3	4.64e-08	161	139	11	593
GeneFamily	Bisphosphoglycerate phosphatases	PGAM1 PGAM2 PGAM4	1.77e-06	4	139	3	1082
GeneFamily	Phosphoinositide phosphatases	INPP1 SACM1L SYNJ1 SYNJ2 MTMR2	4.26e-06	32	139	5	1079
GeneFamily	PRD class homeoboxes and pseudogenes	DUX4L9 DUX4L2 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7	6.93e-06	92	139	7	521
GeneFamily	Immunoglobulin like domain containing	NPHS1 HSPG2 SDK2 MXRA5 AXL NEO1 ICAM5 CNTN3 FCRL5	1.85e-05	193	139	9	594
GeneFamily	WD repeat domain containing	WDR81 DYNC2I1 TEP1 WDR74 AAAS WRAP73 SNRNP40 TLE6	9.61e-04	262	139	8	362
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	AXL ROR1 ALK	3.57e-03	40	139	3	321
GeneFamily	Laminin subunits	LAMA5 LAMB3	3.68e-03	12	139	2	626
GeneFamily	Low density lipoprotein receptors	VLDLR LRP2	4.33e-03	13	139	2	634
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 RUBCNL LAMA5 SRCIN1 DUX4 TENM2 TENM3 ADAMTSL5 LRP2 C3 ALPK2	5.96e-11	158	183	11	e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 RUBCNL LAMA5 SRCIN1 DUX4 TENM2 TENM3 ADAMTSL5 LRP2 C3 ALPK2	5.96e-11	158	183	11	d39e020c3e77eb9d3de600a171d22f94357061d4
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	EPHB4 HSPG2 VWF ITGB4 NR2F2 STAB1 FAR2 NOS3 PALLD PLTP	1.12e-08	200	183	10	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ACE ITGB4 NR2F2 ARHGAP31 NOS3 PLTP	1.22e-07	195	183	9	0c15be3e7c238e329505dcbbe197a977d1019d45
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ACE ITGB4 NR2F2 ARHGAP31 NOS3 PLTP	1.22e-07	195	183	9	45ac0fdbeb0982d798c613a6d15715d725608aa9
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ACE ITGB4 NR2F2 ARHGAP31 NOS3 PLTP	1.22e-07	195	183	9	5b1f04a745467876b09113ee17ababd3fcf9fb01
ToppCell	Epithelial_cells-Basal_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	SDK2 MXRA5 AXL ITGB4 TENM2 TP63 NYNRIN LTBP2 PALLD	1.39e-07	198	183	9	4235005c49fc2b29ad3a0ee6b608f0109d04f775
ToppCell	facs-Aorta-Heart-3m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR EPPK1 AXL ROR1 THBS3 TP63 C3 ALPK2	1.34e-06	192	183	8	0dc1f46e40346ed0b286e53b106a812441575100
ToppCell	droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ITGB4 NR2F2 ARHGAP31 NOS3 PLTP	1.45e-06	194	183	8	17d530982789acc5e6889b215f3d433d138a41c4
ToppCell	droplet-Lung-21m-Endothelial-venous_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ITGB4 NR2F2 ARHGAP31 NOS3 PLTP	1.45e-06	194	183	8	db7b0c77ad88f7b74d85679f1fb8ee7140ac3f62
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF APBB2 ITGB4 NR2F2 STAB1 ARHGAP31 NOS3	1.45e-06	194	183	8	e8102c8811333f04de7280b7d9b6b85cebb815ac
ToppCell	droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ITGB4 NR2F2 ARHGAP31 NOS3 PLTP	1.45e-06	194	183	8	5992b9409d5855eff2afc3acd201ccd25420d2e0
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF APBB2 ITGB4 NR2F2 STAB1 ARHGAP31 NOS3	1.45e-06	194	183	8	4b0d63babb8a46ff45731d5f82b29ccaf6c9402d
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR EPPK1 AXL ISLR THBS3 NEO1 TP63 C3	1.57e-06	196	183	8	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGIP1 AXL NR2F1 NR2F2 TENM3 PDE5A LTBP2 PALLD	1.57e-06	196	183	8	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGIP1 AXL NR2F1 NR2F2 TENM3 PDE5A LTBP2 PALLD	1.57e-06	196	183	8	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	SDK2 MXRA5 LAMA5 LAMB3 ITGB4 TENM2 TP63 NYNRIN	1.63e-06	197	183	8	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	SGIP1 ISLR NR2F1 NR2F2 PDE5A LTBP2 PALLD PLTP	1.63e-06	197	183	8	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	MXRA5 SGIP1 ROR1 APBB2 NR2F1 TENM3 LTBP2 PALLD	1.63e-06	197	183	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	SGIP1 ISLR NR2F1 NR2F2 PDE5A C3 LTBP2 PALLD	1.69e-06	198	183	8	2d7842f352273b6b823c86eb548b9f4a4cddf0ae
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB4 HSPG2 VWF LAMA5 LCN6 NR2F2 ARHGAP31 NOS3	1.75e-06	199	183	8	07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 MXRA5 POLD1 ISLR NR2F1 TENM3 C3 PALLD	1.75e-06	199	183	8	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	distal-2-Endothelial-Artery\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSPG2 VWF ITGB4 LCN6 SYNJ2 NOS3 PALLD PLTP	1.75e-06	199	183	8	fa8aaf7a90699e41a7a4cee5614f8c9248110327
ToppCell	3'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 VWF TCN2 HLA-DMA LAMA5 LCN6 NR2F2 ARHGAP31	1.75e-06	199	183	8	f5c8ad751d21ea0b199a02846faecd04bf100033
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 MXRA5 POLD1 ISLR NR2F1 TENM3 C3 PALLD	1.75e-06	199	183	8	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	SDK2 AXL LAMB3 ITGB4 TENM2 TP63 LTBP2 PALLD	1.75e-06	199	183	8	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB4 HSPG2 VWF LAMA5 LCN6 NR2F2 ARHGAP31 NOS3	1.82e-06	200	183	8	cd3c638961144a2fc91c437a173cc37c7452fa74
ToppCell	Parenchymal-10x3prime_v2-Stromal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	AXL ISLR NR2F1 NR2F2 C3 LTBP2 PALLD PLTP	1.82e-06	200	183	8	f6be0f24e607abb9007823a54fb0b24d04990a89
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Vein\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPHB4 VWF ITGB4 NR2F2 STAB1 FAR2 NOS3 PLTP	1.82e-06	200	183	8	7eb366b2c5394af7c77650bde6261e7dac67154e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH3 RCCD1 FXR2 THBS3 ARHGAP31 TTC5 HOMEZ	2.06e-06	142	183	7	ae495c8dd733f0fde66bddc281606543f21c0d4b
ToppCell	Adult-Mesenchymal-chondrocyte-D231\|Adult / Lineage, Cell type, age group and donor	SDK2 MXRA5 SGIP1 PLEKHA4 NR2F2 NYNRIN LTBP2	5.33e-06	164	183	7	2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMA AXL SRCIN1 IDUA ITGAX FCRL5 PLTP	5.78e-06	166	183	7	91eeb48680dd07ae4115afacdc0a8f6fa18885e5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 SGIP1 FASN KCNA5 TENM3 ICAM5 PALLD	7.02e-06	171	183	7	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 SGIP1 FASN KCNA5 TENM3 ICAM5 PALLD	7.02e-06	171	183	7	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLBD1 HLA-DMA AXL EXTL2 ITGAX FASN	7.73e-06	114	183	6	84318a25a701331ccd5e68221239c543b9c0cc54
ToppCell	Control-Epithelial_alveolar-AT_2-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP65 B3GNT6 FASN ICAM5 ALPK2 SBK2	8.97e-06	117	183	6	c6fc72608d56a389bcd87b5dc98a11e39b79bcb2
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ITGB4 NR2F2 ARHGAP31 NOS3	9.12e-06	178	183	7	ccd37575b60102f5e647c01546e8ff8fec638bd7
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ITGB4 NR2F2 ARHGAP31 NOS3	9.12e-06	178	183	7	87b04753650e45f12299c8456fb980d6c0d5961c
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF APBB2 ITGB4 NR2F2 ARHGAP31 NOS3	9.12e-06	178	183	7	ebfae386a518ea33911ba3ff40464c94d18ef695
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-mLTo\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APBB2 NR2F1 NR2F2 ICAM5 TP63 C3 ALPK2	9.80e-06	180	183	7	f103e161e966c257eac97e1b30a461c4ed9cafc2
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 VWF TCN2 LAMA5 LCN6 STAB1 NOS3	1.09e-05	183	183	7	a644258ba90acc62d571623e429d72ffc4b69203
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 NR2F2 STAB1 PLA2G4F NOS3 IL27RA	1.09e-05	183	183	7	6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	VWF ACE ITGB4 KCNA5 NOS3 PLTP C16orf54	1.13e-05	184	183	7	7e1a2971321ddcfa00d78d3e3ba7960e532f9392
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 VWF TCN2 ITGB4 NR2F2 FAR2 PALLD	1.21e-05	186	183	7	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PLBD1 INPP1 PPM1M WDR81 CRY2 SYNJ1 PALLD	1.35e-05	189	183	7	a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SDK2 DUSP14 LAMB3 TENM2 TP63 LTBP2 ADGRA3	1.35e-05	189	183	7	38acb307907fde68b992057714448c1561d69ee3
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP14 LAMB3 ANKLE1 TENM2 TP63 LTBP2 ADGRA3	1.35e-05	189	183	7	6f0fc5271a7d3682f145e734abc3be6473dda2e2
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLBD1 INPP1 PPM1M WDR81 CRY2 SYNJ1 PALLD	1.35e-05	189	183	7	54a45b0cb7dea01caf1cf0a2664c40e5779a0b61
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP14 LAMB3 ANKLE1 TENM2 TP63 LTBP2 ADGRA3	1.35e-05	189	183	7	3b9ce8964b16cb2200d30cbb0bfc711dcad2380e
ToppCell	droplet-Lung-nan-21m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF APBB2 ITGB4 ARHGAP31 NOS3 PLTP	1.44e-05	191	183	7	92b2faa72c184b6ae49530fd3b50848510904997
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF ITGB4 NR2F2 NYNRIN NOS3 PLTP	1.44e-05	191	183	7	9fc674a58f20b47255e4457d5195c8cff17b0414
ToppCell	P07-Endothelial-large_vessel_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EPHB4 VWF APBB2 ACE ITGB4 ARHGAP31 NOS3	1.44e-05	191	183	7	d162917816dd2e4767c97447c1cddae9397713ab
ToppCell	droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF ITGB4 NR2F2 NYNRIN NOS3 PLTP	1.44e-05	191	183	7	c379a499dabf3c9ed80f47adbb2d949821c5b053
ToppCell	droplet-Lung-nan-21m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF APBB2 ITGB4 ARHGAP31 NOS3 PLTP	1.44e-05	191	183	7	d0bbbf42d00165a53253c833adef65da6ec36bba
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	SDK2 MXRA5 LAMA5 LAMB3 ITGB4 TENM2 TP63	1.44e-05	191	183	7	a98915bad9a4a61dd4cbca798914849b805f4a19
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)-\|Striatum / BrainAtlas - Mouse McCarroll V32	NPHS1 FAM47C TP63 RPE65 SBK2	1.44e-05	75	183	5	162b69b9934da4623ee378b0e8206c4e4917351b
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)\|Striatum / BrainAtlas - Mouse McCarroll V32	NPHS1 FAM47C TP63 RPE65 SBK2	1.44e-05	75	183	5	98807389b7735b90024ba5e71be60cf95416c077
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1-Sparc\|Striatum / BrainAtlas - Mouse McCarroll V32	NPHS1 FAM47C TP63 RPE65 SBK2	1.44e-05	75	183	5	15505f3e7a25b3ae51f0917335e92d6279e6d06d
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF ITGB4 NR2F2 NYNRIN NOS3 PLTP	1.49e-05	192	183	7	1990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCell	droplet-Lung-nan-18m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF APBB2 ITGB4 ARHGAP31 NOS3 PLTP	1.49e-05	192	183	7	45929c757d873fe314cc36d27abd265414635490
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 TCN2 ACE STAB1 ARHGAP31 PLTP ADGRA3	1.49e-05	192	183	7	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF ITGB4 NR2F2 NYNRIN NOS3 PLTP	1.49e-05	192	183	7	845cc9c18b4436b07dd3ce7980052683937546d2
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF ITGB4 NR2F2 NYNRIN NOS3 PLTP	1.49e-05	192	183	7	c72a082c93a8825adbfef37f889ba3a7052f201b
ToppCell	droplet-Lung-nan-18m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF APBB2 ITGB4 ARHGAP31 NOS3 PLTP	1.49e-05	192	183	7	beb336d3479821bdab7e8e2c58812f155e44e9a2
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	EPHB4 HSPG2 VWF TCN2 NR2F1 NR2F2 STAB1	1.49e-05	192	183	7	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB4 HSPG2 VWF STAB1 FAR2 ARHGAP31 NOS3	1.49e-05	192	183	7	25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 VWF ITGB4 NR2F2 FAR2 NOS3 PLTP	1.49e-05	192	183	7	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB4 HSPG2 VWF HLA-DMA ISLR ITGB4 STAB1	1.54e-05	193	183	7	daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 AXL ROR1 ISLR THBS3 NEO1 C3	1.54e-05	193	183	7	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 VWF ITGB4 STAB1 FAR2 NOS3 PLTP	1.54e-05	193	183	7	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SDK2 SGIP1 TENM2 NR2F1 NR2F2 PDE5A PALLD	1.54e-05	193	183	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	droplet-Lung-3m-Endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB4 VWF TCN2 ACE STAB1 ARHGAP31 PLTP	1.54e-05	193	183	7	95c9c63bddfed1a84393ccd3578cfe65bc0c1c05
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MXRA5 SGIP1 ISLR NR2F1 KCNA5 LTBP2 PALLD	1.54e-05	193	183	7	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL LAMA5 NR2F2 KCNA5 ADAMTSL5 PDE5A PALLD	1.59e-05	194	183	7	bf34737ae2dc218f890fbb9201c308b324415749
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSPG2 AXL ISLR NR2F2 KCNA5 PDE5A LTBP2	1.59e-05	194	183	7	aaecde88bd54134a938e76cdf059c1c2653e4e77
ToppCell	facs-Trachea-nan-3m-Epithelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 EPPK1 LAMA5 LAMB3 ITGB4 LRP2 SLC44A3	1.59e-05	194	183	7	3701ca87c6dc9ccd7b4146e56371546174d26c36
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HSPG2 VWF TCN2 ITGB4 STAB1 FAR2 NOS3	1.59e-05	194	183	7	efd5efed060edb7f24d59600981bb60ec28ac2ef
ToppCell	facs-Trachea-nan-3m-Epithelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 EPPK1 LAMA5 LAMB3 ITGB4 LRP2 SLC44A3	1.59e-05	194	183	7	65f9bf126be26114c2c3f4c46d48318986212a92
ToppCell	droplet-Lung-nan-18m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF TCN2 ACE ARHGAP31 PLTP ADGRA3	1.59e-05	194	183	7	faaa7f18667e8943528fd0e92b7988e5b0607b54
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	MXRA5 NR2F2 LIMK1 TENM3 TP63 LTBP2 NOS3	1.59e-05	194	183	7	eaeeb84576270cc3fc59002ba33bff9639bb0b02
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL LAMA5 NR2F2 KCNA5 ADAMTSL5 PDE5A PALLD	1.59e-05	194	183	7	4ebed7a6731b88c8359860072cbeba355a7e90ac
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 DUSP14 LAMB3 TENM2 LTBP2 PALLD ADGRA3	1.65e-05	195	183	7	717e6a66bad50e711442d71360b540789646b334
ToppCell	Mesenchymal_cells-Stromal_fibro.\|World / Lineage and Cell class	HSPG2 AXL ISLR TENM2 NR2F2 THBS3 PLTP	1.65e-05	195	183	7	69723b06c2a5c2aaf4d10874b11bca7f06822bdc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGIP1 AXL NR2F1 NR2F2 TENM3 PDE5A PALLD	1.65e-05	195	183	7	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 DUSP14 LAMB3 TENM2 LTBP2 PALLD ADGRA3	1.65e-05	195	183	7	10774b5ce17d4edd23dbf4709b11cc87cc2b87be
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SGIP1 ROR1 TENM2 NR2F1 NR2F2 NEO1 MBD5	1.65e-05	195	183	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB4 HSPG2 VWF TCN2 HLA-DMA NR2F2 STAB1	1.65e-05	195	183	7	9ad4981c4d157edc752de206ab0d754aa14beab8
ToppCell	facs-Heart-RA-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 VWF APBB2 STAB1 KCNA5 ARHGAP31 NOS3	1.65e-05	195	183	7	30c75761079fa1e1a3b84d23c88a222f459d5ce5
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	MXRA5 SGIP1 ROR1 ISLR NR2F1 TENM3 LTBP2	1.70e-05	196	183	7	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL LAMA5 ISLR NR2F2 KCNA5 PDE5A PALLD	1.70e-05	196	183	7	184104cbea0461dd2757668ab9755948ac7b585a
ToppCell	343B-Endothelial_cells-Endothelial-D-\|343B / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 VWF TCN2 ITGB4 LCN6 NR2F2 STAB1	1.70e-05	196	183	7	5edffdc4c1ff35d9ee0e5c1bed0dc0c90b76ea00
ToppCell	343B-Endothelial_cells-Endothelial-D\|343B / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 VWF TCN2 ITGB4 LCN6 NR2F2 STAB1	1.70e-05	196	183	7	99953fe0a40e242f6945150345fc0a08ed95f8f9
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SDK2 LAMA5 LAMB3 ITGB4 TENM2 TP63 NYNRIN	1.70e-05	196	183	7	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	LAM-Mesenchyme-Mesenchyme\|LAM / Condition, Lineage and Cell class	MXRA5 ISLR NR2F1 NR2F2 KCNA5 PDE5A LTBP2	1.70e-05	196	183	7	4590fb157797a68dca4295e203702bbae279cd03
ToppCell	LAM-Mesenchyme\|LAM / Condition, Lineage and Cell class	MXRA5 ISLR NR2F1 NR2F2 KCNA5 PDE5A LTBP2	1.70e-05	196	183	7	e7918b0cd5eeb675012f871f43f4388471845035
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AXL LAMA5 ISLR NR2F2 KCNA5 PDE5A PALLD	1.70e-05	196	183	7	8114e98923096c54b6834f21550c3061bab6773d
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 DUSP14 LAMB3 ITGB4 TENM2 LTBP2 PALLD	1.76e-05	197	183	7	f4dad4423384a2a25e064c849ffccf2811573be0
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPHB4 HSPG2 VWF TCN2 LCN6 NR2F2 NOS3	1.76e-05	197	183	7	8437c33e2c4a10a1b95343431e48d5e820b1f742
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 HSPG2 TCN2 APBB2 NR2F2 STAB1 ARHGAP31	1.76e-05	197	183	7	a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPHB4 HSPG2 VWF TCN2 LCN6 NR2F2 NOS3	1.76e-05	197	183	7	0542badae77d2f606c13cfaf361319495c354351
Drug	Flumequine [42835-25-6]; Down 200; 15.4uM; MCF7; HT_HG-U133A	TAF1C SRCAP IDUA NR2F1 DIMT1 SYNJ1 PHF3 ZNF589 PAFAH2 C3 LTBP2	8.24e-07	198	188	11	2276_DN
Drug	THIP Hydrochloride; Down 200; 22.6uM; MCF7; HT_HG-U133A	VLDLR FXR2 YIPF4 RNPEPL1 LIMK1 SYNJ2 PHF3 MTMR2 PKNOX1 N4BP1 LTBP2	8.66e-07	199	188	11	6511_DN
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; HL60; HT_HG-U133A	LILRA2 LAMB3 SRCAP PGAM2 ZNF446 KCNA5 SYNJ1 PAFAH2 LRP2 LTBP2	5.88e-06	197	188	10	2435_UP
Drug	Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	FXR2 ITGB4 NR2F1 SYNJ1 PAFAH2 SHARPIN MAP3K9 C3 LTBP2 SMG6	5.88e-06	197	188	10	2645_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	DNAH3 AP5S1 NAB1 AAAS SYNJ2 CCSER2 MTMR2 PKNOX1 CABIN1 IL27RA	6.15e-06	198	188	10	1332_DN
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A	LIMK1 TENM3 SYNJ2 PHF3 ZNF589 TTC12 CCSER2 LRP2 MAP3K9	3.53e-05	194	188	9	2238_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	EPHB4 APBB2 ZNF446 TENM3 ZNF589 LRP2 C3 IKBKB SMG6	3.67e-05	195	188	9	3871_DN
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	CTC1 NAB1 SRCAP PAFAH2 PKNOX1 LRP2 ALK MTMR9 IL27RA	3.67e-05	195	188	9	1162_UP
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	DUOX2 IDUA ITGB4 MEP1B LIMK1 SYNJ2 NYNRIN PLTP IL27RA	3.82e-05	196	188	9	3171_UP
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	FXR2 TAF1C ZNF446 DIMT1 PAFAH2 MTMR2 PKNOX1 LRP2 N4BP1	3.82e-05	196	188	9	3233_DN
Drug	SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A	HSPG2 SLC4A8 INPP1 ITGB4 LIMK1 TP63 ZNF589 PAFAH2 SLC24A1	3.82e-05	196	188	9	6887_UP
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A	HSPG2 VLDLR CTC1 SRCAP CRY2 SYNJ2 PAFAH2 N4BP1 IL27RA	3.82e-05	196	188	9	7092_UP
Drug	Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	TEP1 SFXN1 MEP1B SYNJ2 MTHFR MTMR2 MAP3K9 N4BP1 IL27RA	3.82e-05	196	188	9	6229_UP
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; HL60; HT_HG-U133A	LILRA2 CTC1 LAMA5 ITGB4 ZNF446 NR2F2 ICAM5 SLC22A5 CCSER2	3.98e-05	197	188	9	3024_UP
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A	EPPK1 TAF1C SYNJ2 MTHFR PHF3 ZNF589 LRP2 MAP3K9 CABIN1	3.98e-05	197	188	9	4761_DN
Drug	ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A	SLC4A8 NAB1 LAMB3 NR2F2 MEP1B PHF3 ICAM5 PAFAH2 IL27RA	3.98e-05	197	188	9	2698_UP
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	EPPK1 SRCAP TEP1 NR2F1 LIMK1 SYNJ2 C3 IL27RA SMG6	3.98e-05	197	188	9	3364_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; HL60; HT_HG-U133A	EPHB4 LILRA2 ITGB4 NR2F2 THBS4 SYNJ2 CCSER2 LRP2 N4BP1	3.98e-05	197	188	9	2131_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; PC3; HT_HG-U133A	AAAS SYNJ2 ZNF589 PAFAH2 MTMR2 MAP3K9 CDC73 IKBKB CABIN1	4.14e-05	198	188	9	1806_UP
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	ZSWIM8 CTC1 APBB2 ZNF446 NR2F1 CRY2 ZNF589 PKNOX1 SLC24A1	4.14e-05	198	188	9	5445_DN
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	IDUA WDR74 LIMK1 FASN TENM3 ARHGEF1 LRP2 N4BP1 CABIN1	4.30e-05	199	188	9	4294_DN
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; HL60; HT_HG-U133A	HSPG2 LILRA2 YIPF4 WDR74 SCML2 PHF3 PKNOX1 N4BP1 SLC24A1	4.30e-05	199	188	9	1281_DN
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	FXR2 INPP1 NR2F1 THBS3 THBS4 DIMT1 LTBP2 ALK SMG6	4.30e-05	199	188	9	2640_UP
Drug	Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A	VLDLR YIPF4 LAMB3 SFXN1 ZNF589 CCSER2 C3 SLC24A1 CABIN1	4.30e-05	199	188	9	2822_UP
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SCAF8 APBB2 NR2F1 TENM3 SYNJ2 PHF3 MTMR2 LRP2 LTBP2	4.48e-05	200	188	9	4818_DN
Drug	1,3-diphosphoglycerate	PGAM1 PGAM2 FAR2 PGAM4 TTC5	4.67e-05	48	188	5	CID000000683
Drug	AC1L9INI	HSPG2 LAMA5 LAMB3 ITGB4 C3	1.27e-04	59	188	5	CID000445839
Drug	AC1NBT2J	TCN2 ACE ABCC6 MTHFR	1.35e-04	32	188	4	CID003958805
Drug	carvedilol	NPHS1 ACE FASN KCNA5 IKBKB BECN1 NOS3	1.39e-04	136	188	7	ctd:C043211
Drug	Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	AP5S1 CTC1 AXL APBB2 ITGB4 MTHFR PAFAH2 CCSER2	1.51e-04	184	188	8	2946_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	AP5S1 SCAF8 DDX60 NR2F2 WDR74 FAR2 PKNOX1 IL27RA	1.57e-04	185	188	8	5882_DN
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	HSPG2 APBB2 IDUA TEP1 SYNJ2 ARHGEF1 PAFAH2 IKBKB	2.02e-04	192	188	8	3729_DN
Drug	SC 19220; Down 200; 10uM; PC3; HT_HG-U133A	EPHB4 HSPG2 EPPK1 SRCAP THBS3 PHF3 PAFAH2 N4BP1	2.02e-04	192	188	8	7065_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	HSPG2 FXR2 YIPF4 APBB2 TEP1 ITGB4 PAFAH2 C3	2.09e-04	193	188	8	4338_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	VLDLR DYNC2I1 IDUA NYNRIN PAFAH2 SLC24A1 CABIN1 PLTP	2.09e-04	193	188	8	3296_UP
Drug	Allopurinol	FASN SLC22A5 PDE5A IKBKB NOS3	2.16e-04	66	188	5	ctd:D000493
Drug	InsP5	INPP1 INO80 PGAM1 PGAM2 PGAM4	2.16e-04	66	188	5	CID000000482
Drug	Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; HL60; HT_HG-U133A	HSPG2 LILRA2 CTC1 NAB1 NR2F2 SYNJ1 ZNF589 CCSER2	2.17e-04	194	188	8	2741_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	DNAH3 LILRA2 TRIM58 DDX60 ITGAX NR2F2 ZNF589 CABIN1	2.17e-04	194	188	8	1185_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	HSPG2 VLDLR TAF1C APBB2 TEP1 PAFAH2 LRP2 ALK	2.17e-04	194	188	8	3422_UP
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A	DNAH3 RNPEPL1 LAMA5 LAMB3 ITGB4 LIMK1 N4BP1 CABIN1	2.17e-04	194	188	8	3570_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A	TTC12 PAFAH2 MTMR2 MAP3K9 PDE5A SLC24A1 IL27RA SMG6	2.25e-04	195	188	8	2085_UP
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A	LILRA2 TAF1C SRCAP ITGB4 MEP1B PHF3 ZNF589 SLC24A1	2.25e-04	195	188	8	2727_DN
Drug	Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; PC3; HT_HG-U133A	HSPG2 CTC1 ROR1 NAB1 THBS3 PHF3 PAFAH2 SLC24A1	2.25e-04	195	188	8	4229_DN
Drug	Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A	EPHB4 LILRA2 SRCAP ITGB4 NR2F2 MEP1B PHF3 PLTP	2.25e-04	195	188	8	2708_DN
Drug	2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A	LILRA2 TRIM58 APBB2 EXTL2 MTHFR PAFAH2 CCSER2 LRP2	2.32e-04	196	188	8	1155_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	DDX60 APBB2 SRCAP TEP1 ZNF446 STAB1 SLC24A1 CABIN1	2.32e-04	196	188	8	5253_UP
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	SRCAP TEP1 ZNF446 LIMK1 SYNJ2 MAP3K9 SLC24A1 CABIN1	2.32e-04	196	188	8	5568_DN
Drug	Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A	HSPG2 TAF1C NR2F1 LIMK1 PHF3 ARHGEF1 PAFAH2 LRP2	2.32e-04	196	188	8	2236_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	NR2F1 THBS3 SYNJ2 PHF3 PAFAH2 PKNOX1 IKBKB CABIN1	2.32e-04	196	188	8	7228_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	CTC1 SRCAP TEP1 ZNF446 CRY2 PHF3 PKNOX1 C3	2.32e-04	196	188	8	3872_DN
Drug	Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A	EPHB4 APBB2 SRCAP TENM3 SYNJ2 MTHFR ZNF589 LTBP2	2.32e-04	196	188	8	6007_DN
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	VLDLR RNPEPL1 APBB2 SRCAP NR2F1 CRY2 DIMT1 ZNF589	2.32e-04	196	188	8	4415_DN
Drug	Sulfadoxine [2447-57-6]; Up 200; 12.8uM; PC3; HT_HG-U133A	EPPK1 FXR2 RNPEPL1 NAB1 ZNF446 MTHFR LRP2 ALK	2.32e-04	196	188	8	5852_UP
Drug	Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A	APBB2 TEP1 MTHFR SHARPIN N4BP1 LTBP2 IKBKB SLC24A1	2.32e-04	196	188	8	3475_UP
Drug	Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A	NEO1 ZNF589 PKNOX1 MAP3K9 SLC24A1 ALK IL27RA SMG6	2.32e-04	196	188	8	3767_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	HSPG2 SLC4A8 TAF1C ITGB4 SYNJ2 PHF3 MTMR2 C3	2.41e-04	197	188	8	3319_DN
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A	FXR2 DDX60 SRCAP STAB1 THBS3 DIMT1 SLC24A1 CABIN1	2.41e-04	197	188	8	2888_UP
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A	EPHB4 ZSWIM8 AP5S1 TAF1C IDUA MTHFR URM1 SLC24A1	2.41e-04	197	188	8	3143_UP
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A	NR2F1 LIMK1 SYNJ1 SYNJ2 ARHGEF1 NYNRIN MAP3K9 SLC24A1	2.41e-04	197	188	8	1506_UP
Drug	Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A	HSPG2 DNAH3 SLC4A8 NR2F2 DIMT1 PHF3 ZNF589 MTMR2	2.41e-04	197	188	8	1499_DN
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; PC3; HT_HG-U133A	DDX60 SRCAP ITGB4 NR2F2 ERAP2 PHF3 CCSER2 N4BP1	2.41e-04	197	188	8	1796_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A	LILRA2 AP5S1 TAF1C APBB2 SRCAP PHF3 CCSER2 PLTP	2.41e-04	197	188	8	2554_DN
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A	ZNF446 CRY2 LIMK1 ERAP2 ZNF589 URM1 N4BP1 IL27RA	2.41e-04	197	188	8	6440_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A	EPHB4 THBS3 PHF3 ARHGEF1 ZNF589 PKNOX1 N4BP1 SLC24A1	2.41e-04	197	188	8	7197_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; HL60; HT_HG-U133A	EPHB4 CTC1 APBB2 NR2F1 CRY2 CCSER2 SLC24A1 IL27RA	2.41e-04	197	188	8	3112_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	EPHB4 CTC1 RNPEPL1 TAF1C SRCAP PAFAH2 SHARPIN LRP2	2.41e-04	197	188	8	1485_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; PC3; HT_HG-U133A	ROR1 APBB2 DUOX2 ACE WDR74 LIMK1 PHF3 NYNRIN	2.41e-04	197	188	8	4684_DN
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	DYNC2I1 TEP1 ZNF446 NR2F1 PHF3 LTBP2 SLC24A1 IL27RA	2.41e-04	197	188	8	2860_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	DNAH3 APBB2 LAMA5 NR2F1 DIMT1 LRP2 CABIN1 SMG6	2.41e-04	197	188	8	3566_DN
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; HL60; HT_HG-U133A	EPHB4 AMPD2 RNPEPL1 ITGB4 THBS4 ZNF589 PAFAH2 C3	2.41e-04	197	188	8	2130_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; HL60; HT_HG-U133A	APBB2 ITGAX MEP1B PHF3 ICAM5 N4BP1 PLTP IL27RA	2.41e-04	197	188	8	2356_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	APBB2 ITGB4 ARHGEF1 TP63 ZNF589 PAFAH2 LRP2 SLC24A1	2.41e-04	197	188	8	3622_DN
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	EPHB4 ZSWIM8 FXR2 ZCCHC8 DDX60 NR2F2 AAAS PKNOX1	2.49e-04	198	188	8	2080_DN
Drug	Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A	SRCAP ITGB4 LIMK1 SYNJ2 NYNRIN ZNF589 SLC24A1 SMG6	2.49e-04	198	188	8	3402_DN
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	YIPF4 APBB2 NR2F2 SCML2 SYNJ1 MTMR2 MAP3K9 IKBKB	2.49e-04	198	188	8	4792_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	DNAH3 SLC4A8 TAF1C LAMA5 TEP1 THBS3 MTHFR SHARPIN	2.49e-04	198	188	8	7003_DN
Drug	Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A	DNAH3 AXL SRCAP ITGB4 PHF3 ARHGEF1 ZNF589 PKNOX1	2.49e-04	198	188	8	1812_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	EPHB4 INPP1 RNPEPL1 APBB2 LIMK1 DIMT1 MTHFR SHARPIN	2.49e-04	198	188	8	5684_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	EPHB4 ZSWIM8 FXR2 DYNC2I1 THBS3 PAFAH2 SLC24A1 CABIN1	2.49e-04	198	188	8	7174_DN
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A	HSPG2 EPPK1 CTC1 RNPEPL1 APBB2 DIMT1 ZNF589 CABIN1	2.49e-04	198	188	8	6742_DN
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A	LAMB3 SCML2 SYNJ2 PHF3 ARHGEF1 ZNF589 SHARPIN LRP2	2.49e-04	198	188	8	2882_DN
Drug	ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A	VLDLR APBB2 TEP1 SYNJ2 MTHFR ARHGEF1 PAFAH2 IL27RA	2.58e-04	199	188	8	1179_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	DNAH3 APBB2 IDUA ITGB4 ZNF446 CRY2 PHF3 LRP2	2.58e-04	199	188	8	3344_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA	EPHB4 SLC4A8 TAF1C SRCAP DIMT1 NYNRIN ZNF589 CABIN1	2.58e-04	199	188	8	1009_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; HL60; HT_HG-U133A	LILRA2 AXL TAF1C MEP1B SYNJ1 PAFAH2 LTBP2 IL27RA	2.58e-04	199	188	8	3063_DN
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A	EPHB4 DDX60 SLC22A5 ZNF589 MTMR2 SHARPIN LRP2 LTBP2	2.58e-04	199	188	8	2400_DN
Drug	iloprost; Up 200; 1uM; SKMEL5; HG-U133A	ZSWIM8 DNAH3 LILRA2 FXR2 IDUA NR2F2 ZNF589 ALK	2.58e-04	199	188	8	496_UP
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A	APBB2 SRCAP NR2F2 LIMK1 C3 N4BP1 IKBKB ALK	2.58e-04	199	188	8	4561_DN
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A	HSPG2 ITGB4 DIMT1 MTHFR CPSF1 SLC24A1 ALK PALLD	2.58e-04	199	188	8	3101_UP
Drug	Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A	TRIM46 HSPG2 FXR2 NR2F1 ARHGEF1 TP63 MAP3K9 PLTP	2.58e-04	199	188	8	2655_UP
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	LAMB3 NR2F1 DIMT1 PHF3 LRP2 MAP3K9 IL27RA SMG6	2.58e-04	199	188	8	3564_DN
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A	EPHB4 APBB2 SRCAP MEP1B ICAM5 PAFAH2 PKNOX1 SLC24A1	2.58e-04	199	188	8	2731_DN
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	HSPG2 ZSWIM8 CRY2 LIMK1 KCNA5 TP63 NYNRIN C3	2.58e-04	199	188	8	3934_UP
Drug	Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A	AMPD2 YIPF4 ZNF446 CRY2 THBS3 PAFAH2 SHARPIN IKBKB	2.58e-04	199	188	8	3249_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	ZSWIM8 EPPK1 APBB2 IDUA NR2F1 LIMK1 SLC24A1 PLTP	2.67e-04	200	188	8	3322_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; HL60; HT_HG-U133A	EPHB4 CTC1 DDX60 TAF1C NR2F2 CRY2 MTHFR SLC24A1	2.67e-04	200	188	8	2453_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A	AMPD2 AXL DDX60 SCML2 PHF3 CCSER2 MTMR2 IKBKB	2.67e-04	200	188	8	2175_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	HSPG2 AMPD2 SLC4A8 TAF1C SRCAP ITGB4 MTMR2 URM1	2.67e-04	200	188	8	1666_DN
Drug	Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A	ZSWIM8 FXR2 TAF1C TP63 NYNRIN PAFAH2 N4BP1 SLC24A1	2.67e-04	200	188	8	6488_UP
Disease	Autistic Disorder	VLDLR TCN2 INPP1 TAF1C ACE SLC25A12 MTHFR CNTN3 TBR1	3.31e-05	261	179	9	C0004352
Disease	mitral valve disease (is_implicated_in)	ACE MTHFR	3.66e-05	2	179	2	DOID:61 (is_implicated_in)
Disease	Cardiovascular Diseases	VWF ACE MTHFR NOS3	6.63e-05	36	179	4	C0007222
Disease	hypertension (biomarker_via_orthology)	HSPG2 VWF ACE KCNA5 C3 IKBKB BECN1 NOS3	7.84e-05	227	179	8	DOID:10763 (biomarker_via_orthology)
Disease	Cleft upper lip	TCN2 MTHFR TP63 NOS3	9.12e-05	39	179	4	C0008924
Disease	Proteinuria	VWF LRP2 SMG6	9.47e-05	15	179	3	HP_0000093
Disease	Colorectal Carcinoma	DNAH3 TCN2 POLD1 RNPEPL1 LAMB3 ISLR ABCC6 SFXN1 MTHFR ICAM5 ARHGEF1 TP63 PKNOX1 LRP2	1.05e-04	702	179	14	C0009402
Disease	Indirect Hyperbilirubinemia, Neonatal	NCOR1 IKBKB	1.09e-04	3	179	2	C1565886
Disease	Direct Hyperbilirubinemia, Neonatal	NCOR1 IKBKB	1.09e-04	3	179	2	C1565885
Disease	Hyperbilirubinemia, Neonatal	NCOR1 IKBKB	1.09e-04	3	179	2	C0857007
Disease	end stage renal disease (is_implicated_in)	VWF ACE MTHFR NOS3	1.11e-04	41	179	4	DOID:783 (is_implicated_in)
Disease	sickle cell anemia (is_implicated_in)	MTHFR C3 NOS3	1.16e-04	16	179	3	DOID:10923 (is_implicated_in)
Disease	Kuhnt-Junius degeneration (is_implicated_in)	MTHFR C3 NOS3	1.40e-04	17	179	3	DOID:10873 (is_implicated_in)
Disease	glomerulonephritis (implicated_via_orthology)	AXL ACE C3	1.40e-04	17	179	3	DOID:2921 (implicated_via_orthology)
Disease	end stage renal disease (biomarker_via_orthology)	NPHS1 LRP2 BECN1 NOS3	1.91e-04	47	179	4	DOID:783 (biomarker_via_orthology)
Disease	Herlitz Disease	LAMB3 ITGB4	2.18e-04	4	179	2	C0079683
Disease	Epidermolysis Bullosa Progressiva	LAMB3 ITGB4	2.18e-04	4	179	2	C0079297
Disease	cerebellar ataxia, mental retardation and dysequlibrium syndrome (is_implicated_in)	VLDLR WDR81	2.18e-04	4	179	2	DOID:0050997 (is_implicated_in)
Disease	COVID-19 (is_implicated_in)	ACE C3 IFNL1	2.69e-04	21	179	3	DOID:0080600 (is_implicated_in)
Disease	systemic scleroderma (is_marker_for)	VWF ACE C3 IL27RA	3.04e-04	53	179	4	DOID:418 (is_marker_for)
Disease	Metastatic melanoma	EPHB4 ROR1 MAP3K9 ALPK2	3.27e-04	54	179	4	C0278883
Disease	non-arteritic anterior ischemic optic neuropathy (is_implicated_in)	ACE MTHFR	3.62e-04	5	179	2	DOID:0050864 (is_implicated_in)
Disease	nephritis (is_implicated_in)	ACE NOS3	3.62e-04	5	179	2	DOID:10952 (is_implicated_in)
Disease	Adult junctional epidermolysis bullosa (disorder)	LAMB3 ITGB4	3.62e-04	5	179	2	C0268374
Disease	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder)	LAMB3 ITGB4	3.62e-04	5	179	2	C2608084
Disease	Dysequilibrium syndrome	VLDLR WDR81	3.62e-04	5	179	2	C0394006
Disease	junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology)	LAMB3 ITGB4	3.62e-04	5	179	2	DOID:0060738 (implicated_via_orthology)
Disease	Coronary Restenosis	ACE MTHFR	3.62e-04	5	179	2	C0948480
Disease	coronary artery disease (is_implicated_in)	ACE ABCC6 ARHGAP31 MTHFR NOS3	3.67e-04	100	179	5	DOID:3393 (is_implicated_in)
Disease	Neoplasm Metastasis	AXL ROR1 ACE MTHFR TP63 PDE5A ALK	3.77e-04	217	179	7	C0027627
Disease	Mammary Carcinoma, Human	EPHB4 RCCD1 ROR1 NR2F1 NCOR1 FASN SYNJ2 MTHFR ICAM5 ALK NOS3	3.86e-04	525	179	11	C4704874
Disease	Mammary Neoplasms, Human	EPHB4 RCCD1 ROR1 NR2F1 NCOR1 FASN SYNJ2 MTHFR ICAM5 ALK NOS3	3.86e-04	525	179	11	C1257931
Disease	Paroxysmal atrial fibrillation	HSPG2 VWF ACE KCNA5 MBD5 NOS3	3.93e-04	156	179	6	C0235480
Disease	familial atrial fibrillation	HSPG2 VWF ACE KCNA5 MBD5 NOS3	3.93e-04	156	179	6	C3468561
Disease	Non-Small Cell Lung Carcinoma	PLBD1 MXRA5 AXL PGAM1 ITGB4 ALK	3.93e-04	156	179	6	C0007131
Disease	Persistent atrial fibrillation	HSPG2 VWF ACE KCNA5 MBD5 NOS3	3.93e-04	156	179	6	C2585653
Disease	Mammary Neoplasms	EPHB4 RCCD1 ROR1 NR2F1 NCOR1 FASN SYNJ2 MTHFR ICAM5 ALK NOS3	3.98e-04	527	179	11	C1458155
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	AARS1 MTMR2 MTMR9	4.05e-04	24	179	3	DOID:10595 (implicated_via_orthology)
Disease	Atrial Fibrillation	HSPG2 VWF ACE KCNA5 MBD5 NOS3	4.49e-04	160	179	6	C0004238
Disease	cortical thickness	HSPG2 ROR1 ESPNL IDUA TENM2 NR2F2 SACM1L STAB1 DNAAF3 THBS3 NEO1 KCNA5 FAR2 MTHFR MTMR2 SHARPIN SMG6	4.63e-04	1113	179	17	EFO_0004840
Disease	Breast Carcinoma	EPHB4 RCCD1 ROR1 NR2F1 NCOR1 FASN SYNJ2 MTHFR ICAM5 ALK NOS3	4.73e-04	538	179	11	C0678222
Disease	Depressive Symptoms	ACE FASN SYNJ2	5.15e-04	26	179	3	C0086132
Disease	Eye Diseases, Hereditary	LRP2 RPE65	5.40e-04	6	179	2	C0015398
Disease	Junctional Epidermolysis Bullosa	LAMB3 ITGB4	5.40e-04	6	179	2	C0079301
Disease	early-onset Parkinson's disease (implicated_via_orthology)	SYNJ1 SYNJ2	5.40e-04	6	179	2	DOID:0060894 (implicated_via_orthology)
Disease	dry eye syndrome (implicated_via_orthology)	FAR2 PLTP	5.40e-04	6	179	2	DOID:10140 (implicated_via_orthology)
Disease	Thrombocytopenia	TCN2 MTHFR MASTL	7.14e-04	29	179	3	C0040034
Disease	neuroblastoma	SGIP1 LAMA5 LAMB3 TENM2 NYNRIN	7.24e-04	116	179	5	EFO_0000621
Disease	cancer antigen 15.3 measurement	TRIM46 THBS3	7.53e-04	7	179	2	EFO_0010585
Disease	junctional epidermolysis bullosa (is_implicated_in)	LAMB3 ITGB4	7.53e-04	7	179	2	DOID:3209 (is_implicated_in)
Disease	CC16 measurement	TRIM46 TP63	7.53e-04	7	179	2	EFO_0005080
Disease	angle-closure glaucoma (is_implicated_in)	MTHFR NOS3	7.53e-04	7	179	2	DOID:13550 (is_implicated_in)
Disease	pulmonary hypertension (is_implicated_in)	VWF KCNA5 NOS3	7.90e-04	30	179	3	DOID:6432 (is_implicated_in)
Disease	Alzheimer disease	SLC4A8 WDR81 SRCIN1 IDUA TENM2 DNAAF3 FAR2 MTMR2 SHARPIN MGME1	8.01e-04	485	179	10	MONDO_0004975
Disease	Malignant neoplasm of breast	EPHB4 VWF RCCD1 ROR1 NR2F1 NCOR1 FASN THBS3 KCNA5 SYNJ2 MTHFR ICAM5 FCRL5 IKBKB ALK NOS3	8.86e-04	1074	179	16	C0006142
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTMR2 MTMR9	1.28e-03	9	179	2	DOID:0111225 (implicated_via_orthology)
Disease	familial Mediterranean fever (is_implicated_in)	ACE MTHFR	1.28e-03	9	179	2	DOID:2987 (is_implicated_in)
Disease	tropical spastic paraparesis (is_marker_for)	C3 IFNL1	1.28e-03	9	179	2	DOID:321 (is_marker_for)
Disease	migraine (is_implicated_in)	MTHFR NOS3	1.28e-03	9	179	2	DOID:6364 (is_implicated_in)
Disease	Alcoholic Intoxication, Chronic	VWF SGIP1 ACE MTHFR PHF3 TTC12 ALK	1.30e-03	268	179	7	C0001973
Disease	Behcet's disease (is_implicated_in)	VWF ACE NOS3	1.35e-03	36	179	3	DOID:13241 (is_implicated_in)
Disease	Colorectal Neoplasms	TCN2 POLD1 ABCC6 SFXN1 MTHFR ICAM5 TP63	1.57e-03	277	179	7	C0009404
Disease	cystic kidney disease (implicated_via_orthology)	EPHB4 LAMA5	1.59e-03	10	179	2	DOID:2975 (implicated_via_orthology)
Disease	pneumonia (implicated_via_orthology)	C3 IKBKB	1.59e-03	10	179	2	DOID:552 (implicated_via_orthology)
Disease	Pulmonary Hypertension	ACE KCNA5 NOS3	1.84e-03	40	179	3	C0020542
Disease	Leukoencephalopathy	TCN2 MTHFR	1.94e-03	11	179	2	C0270612
Disease	X-11315 measurement	SACM1L NAPRT	1.94e-03	11	179	2	EFO_0021223
Disease	Hyperhomocysteinemia	NPHS1 MTHFR	1.94e-03	11	179	2	C0598608
Disease	obstructive sleep apnea (is_implicated_in)	ACE NOS3	1.94e-03	11	179	2	DOID:0050848 (is_implicated_in)
Disease	Diaphragmatic Hernia	NR2F2 LRP2 NOS3	1.98e-03	41	179	3	C0019284
Disease	Nodular glomerulosclerosis	AXL ACE NOS3	1.98e-03	41	179	3	C0017667
Disease	Kidney Diseases	NPHS1 ACE MTHFR LRP2	2.05e-03	88	179	4	C0022658
Disease	stromal cell-derived factor 1 alpha measurement	DNAAF3 TTC12 ADGRA3	2.27e-03	43	179	3	EFO_0008293
Disease	Mitral valve prolapse, response to surgery	LTBP2 SMG6	2.32e-03	12	179	2	EFO_0009951, HP_0001634
Disease	Diabetic Nephropathy	AXL ACE NOS3	2.42e-03	44	179	3	C0011881
Disease	Gastric Adenocarcinoma	EPHB4 AXL MAP3K9	2.58e-03	45	179	3	C0278701
Disease	Bipolar Disorder	INPP1 ROR1 ACE PGAM1 STAB1 CRY2 MTHFR MBD5 NOS3	2.65e-03	477	179	9	C0005586
Disease	pre-eclampsia (implicated_via_orthology)	PDE5A C3	2.73e-03	13	179	2	DOID:10591 (implicated_via_orthology)
Disease	myocardial infarction (biomarker_via_orthology)	VWF ACE C3 BECN1 NOS3	2.99e-03	160	179	5	DOID:5844 (biomarker_via_orthology)
Disease	frontal fibrosing alopecia	EFCAB5 ERAP2 CNTN3	3.11e-03	48	179	3	EFO_0009855
Disease	Male sterility	ACE MTHFR NOS3	3.11e-03	48	179	3	C0917731
Disease	Male infertility	ACE MTHFR NOS3	3.11e-03	48	179	3	C0021364
Disease	Subfertility, Male	ACE MTHFR NOS3	3.11e-03	48	179	3	C0848676
Disease	Metabolic Bone Disorder	CTC1 LRP2	3.17e-03	14	179	2	C0005944
Disease	membranous glomerulonephritis (biomarker_via_orthology)	NPHS1 LRP2	3.17e-03	14	179	2	DOID:10976 (biomarker_via_orthology)
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	TCN2 MTHFR	3.17e-03	14	179	2	C1858991
Disease	atrial fibrillation (is_implicated_in)	VWF ACE	3.17e-03	14	179	2	DOID:0060224 (is_implicated_in)
Disease	anemia (is_implicated_in)	ACE MTHFR	3.17e-03	14	179	2	DOID:2355 (is_implicated_in)
Disease	platelet measurement	EPPK1 VWF TRIM58 RNPEPL1 DYNC2I1 FAR2 SMG6	3.22e-03	315	179	7	EFO_0005036
Disease	developmental disorder of mental health (implicated_via_orthology)	GIGYF1 SRCAP NCOR1	3.30e-03	49	179	3	DOID:0060037 (implicated_via_orthology)
Disease	Acute kidney injury	MTHFR LRP2 C3 NOS3	3.38e-03	101	179	4	C2609414
Disease	Acute Kidney Insufficiency	MTHFR LRP2 C3 NOS3	3.38e-03	101	179	4	C1565662
Disease	Kidney Failure, Acute	MTHFR LRP2 C3 NOS3	3.38e-03	101	179	4	C0022660
Disease	Crohn Disease	ERAP2 MTHFR SLC22A5	3.49e-03	50	179	3	C0010346
Disease	diabetic retinopathy (is_implicated_in)	ACE MTHFR NOS3	3.49e-03	50	179	3	DOID:8947 (is_implicated_in)
Disease	Down syndrome (implicated_via_orthology)	SYNJ1 SYNJ2	3.65e-03	15	179	2	DOID:14250 (implicated_via_orthology)
Disease	Osteopenia	CTC1 LRP2	3.65e-03	15	179	2	C0029453
Disease	disease recurrence, colon carcinoma	ZNF777 TP63 CNTN3	3.69e-03	51	179	3	EFO_0004952, EFO_1001950
Disease	serum gamma-glutamyl transferase measurement	TRIM46 SEC16B SLC4A8 SGIP1 AXL TENM2 STAB1 SYNJ2 C3 ANXA9 CABIN1 PLTP ALPK2	3.96e-03	914	179	13	EFO_0004532
Disease	mitochondrial DNA measurement	VWF TRIM58 RNPEPL1 ANKLE1 FAR2 PKNOX1 MGME1	4.02e-03	328	179	7	EFO_0006312

Protein segments in the cluster

Peptide	Gene	Start	Entry
TRNVPVRDIPAFLTW	SMG6	1401	Q86US8
PDFRGQWINLPVLQL	AAAS	36	Q9NRG9
AARWNRGEPQVPDFR	ARHGEF1	271	Q92888
QWERPVSIPADLQGS	APBB2	316	Q92870
QQFEQPDPARRWREG	ANKLE1	431	Q8NAG6
PREWASLLDFVQVPG	CTC1	1101	Q2NKJ3
PQDWDRVVAVFVQGP	CDC73	436	Q6P1J9
EPIWQNFTDPQLRRI	ACE	106	P12821
GIPAPEEERTRQGWQ	AHSA1	306	O95433
IWQVLQPSEGGERIP	ALPK2	1491	Q86TB3
IGIPEPRVQIWFQNE	DUX4L4	56	P0CJ87
PERVVNNKGDFRWPR	ADGRA3	351	Q8IWK6
LPDNWQLQFIPSEFR	ALG9	481	Q9H6U8
VFQNILKRDIPWPEG	MASTL	786	Q96GX5
FDFVPPVVRWLNEQR	C3	1246	P01024
DPEWGLQPRVTLEQI	C16orf54	196	Q6UWD8
PVIRPNVGFWRQLID	DUSP14	146	O95147
GGEPLNPEVLEQWRV	ACSM4	346	P0C7M7
AAENPFQEPRTVVWL	AP5S1	101	Q9NUS5
PIIQAWLERFPSVER	DNHD1	2541	Q96M86
IGIPEPRVQIWFQNE	DUX4L6	56	P0CJ89
PNVRWLVQVPRLFDV	AMPD2	566	Q01433
PPTWEQLENGLVAVR	RC3H1	371	Q5TC82
RGEPLWAQNVVPEAE	RCCD1	106	A6NED2
RGTEDWAPPRFQIIF	RUBCNL	401	Q9H714
IVPFREQAWQRPDGQ	HSPG2	1056	P98160
EQAWQRPDGQPATRE	HSPG2	1061	P98160
VEWARNIPFFPDLQI	NR2F1	231	P10589
WARNIPFFPDLQITD	NR2F2	226	P24468
GQRDLPVSINFWVPV	ITGAX	961	P20702
AERENIWGPFLIISP	INO80	561	Q9ULG1
RDFLQRPGWQPQAGL	LILRA2	261	Q8N149
RRLRFPPVDTQNWVF	FAM47C	36	Q5HY64
IIRPSIVGATWQEPF	FAR2	226	Q96K12
PRGFWALPENLTVVE	NPHS1	31	O60500
PPRSEAQRQIQEWGV	ESPNL	636	Q6ZVH7
INQPFVSRDPNTLRW	INPP1	201	P49441
PNAVTWGIFPGREII	MTHFR	556	P42898
SWEIRARPGQVFDPR	MPV17L2	46	Q567V2
IGIPEPRVQIWFQNE	DUX4	56	Q9UBX2
LLQGIPRPQDGFTQW	GIGYF1	891	O75420
PPDLFSVEERRQGWV	SLC24A1	441	O60721
LVEPWVVVRGLRPDF	EPHB4	386	P54760
WQSERQIPFGDVRLP	FXR2	46	P51116
ITGFRPFLPNWQPVQ	IKBKB	216	O14920
GEDRRVPQNWFPIFN	MGME1	91	Q9BQP7
VAPQSLPLWEGIFLR	MTMR9	486	Q96QG7
ALRDWVTNPGLFNQP	NAB1	71	Q13506
PSRLPLQFEWRVSEQ	CFAP65	906	Q6ZU64
QGIDIPEPRVQIWFQ	DUX5	81	Q96PT3
PEPRVQIWFQNERSC	DUX5	86	Q96PT3
RETGLPESRIQIWFQ	DUX5	156	Q96PT3
NNFRLGRLPSVPVEW	BECN1	286	Q14457
GRLPSVPVEWNEINA	BECN1	291	Q14457
QWSPTRPAVFLVQDD	DYNC2I1	961	Q8WVS4
DPRVQDFIPDTWQRE	DDX60	756	Q8IY21
GDVVLPFQRSRWDPE	DUOX2	146	Q9NRD8
VWQQFPDQIVGFVPR	EXTL2	166	Q9UBQ6
TLLILFEPNQTWPGR	CPSF1	216	Q10570
FEPNQTWPGRVAVRQ	CPSF1	221	Q10570
PVSWEAIPNARIELQ	CPSF1	1081	Q10570
IGIPEPRVQIWFQNE	DUX4L3	56	P0CJ86
PEGAFREVPLLQSLW	ISLR	66	O14498
LNERTWRGVQIPLPE	PLTP	426	P55058
WRGVQIPLPEGINFV	PLTP	431	P55058
FLQPPWTTVFQGERV	FCRL5	26	Q96RD9
QEPFWADLQPRVAFV	ICAM5	31	Q9UMF0
RCSREGIPWPEQQRV	ICAM5	701	Q9UMF0
GIPWPEQQRVSREDA	ICAM5	706	Q9UMF0
PWPIQQRIAELVATE	PDE5A	771	O76074
RWILEPVPRQNGDRF	FAM214A	126	Q32MH5
RRLRFPPVDTQNWVF	FAM47B	36	Q8NA70
PLLWVLFQRTRPQGS	IL27RA	21	Q6UWB1
PRAQAVWLGRLDPEQ	LCN6	16	P62502
PLLEYRRQGIPNESW	MTMR2	211	Q13614
EPPTVIRDNINWLRD	LRP2	2311	P98164
ARALPFWNEEIVPQI	PGAM4	161	Q8N0Y7
GPSREETWVPVFTQR	ANXA9	211	O76027
PTFPVEVLINAGRVW	LAMA5	1311	O15230
RDPAWSQVALQGPIE	PLA2G4F	406	Q68DD2
WGPEREAIINLATQP	ITGB4	1306	P16144
SPFQARVQALGWPLR	ADAMTSL5	316	Q6ZMM2
PTVQGGLPVFRWDRF	PLBD1	511	Q6P4A8
QERQLRGAVPWAFDP	NOS3	1181	P29474
ECRVRGAPPLQVQWF	PALLD	461	Q8WX93
LRQTISFPPRDEWND	TP63	646	Q9H3D4
DRNVRQPQEGFWKRP	CCSER2	581	Q9H7U1
SLLRNPRQWPFIEFE	EFCAB5	426	A4FU69
PLPRNEFQRQVWLIF	KCNA5	226	P22460
FNGIWRIPVDEIDRP	CABIN1	1581	Q9Y6J0
ETFLEVWGNALLRPP	DNAAF3	111	Q8N9W5
RGQPADVFPRLFKEW	CRY2	96	Q49AN0
VQERRNFGPLGWNIP	DNAH3	3681	Q8TD57
RLLPETPREAFALWQ	COL20A1	906	Q9P218
IGIPEPRVQIWFQNE	DUX4L9	56	Q6RFH8
PVFPGNWDLRLLQVR	IFNL1	71	Q8IU54
NTRVPRLPEFADWAQ	HLA-DMA	76	P28067
QGIDIPEPRVQIWFQ	DUX3	81	Q96PT4
PEPRVQIWFQNERSC	DUX3	86	Q96PT4
RETGLPESRIQLWFQ	DUX3	156	Q96PT4
IGIPEPRVQIWFQNE	DUX4L7	56	P0CJ90
EWRRLGRPVFPTAEQ	IDUA	486	P35475
EFDPQNSRLAPRRWA	LTBP2	226	Q14767
PGWRARQFRVQAVQP	MBLAC2	131	Q68D91
LPAIQVPVGWQRRVD	MBD5	16	Q9P267
ATNGERFPWQELRLP	ERAP2	56	Q6P179
TFPRVRQGRPQSWQD	LAMB3	156	Q13751
SAEGAPRQREWRPQI	SLC44A3	11	Q8N4M1
TAVNDQPVPERRWTV	IGFN1	791	Q86VF2
RRPQWELSPETKFIQ	SDR42E2	66	A6NKP2
QITGLPRPEIIQWFG	HOMEZ	391	Q8IX15
FIQVSRPLPLWRDNR	C1orf127	21	Q8N9H9
QASEEFQPLARPWRA	C1orf127	416	Q8N9H9
IGIPEPRVQIWFQNE	DUX4L5	56	P0CJ88
EVQQVPAGERPLWFI	FASN	481	P49327
LQQWFLQAPRSPREE	B3GNT6	26	Q6ZMB0
FIRQAPVPITWENFE	DNAH2	141	Q9P225
VEQFELWASRARPPV	DNAH2	4261	Q9P225
NRLGRDRIQNTWVPP	SCAF8	1176	Q9UPN6
RIASFPQPQVTWFRD	SDK2	136	Q58EX2
TRGSIPVFWSQRPNL	SACM1L	256	Q9NTJ5
DFLIWQASGQPRDRP	SBK2	276	P0C263
FIPESPRWLISQGRF	SLC22A5	276	O76082
EGPWQRIAPLRVLSF	POLD1	301	P28340
DNADWQRVSQVPRGP	MEP1B	281	Q16820
IPQINWRRSDGLPFS	CNTN3	256	Q9P232
VVFPPTPRRWNTQQD	MAP3K9	966	P80192
ARALPFWNEEIVPQI	PGAM1	161	P18669
PPINFQEWDGLVRIT	DIMT1	216	Q9UNQ2
LIVADPNTRWVEAFP	NYNRIN	1636	Q9P2P1
WGVPVRLEAAQGPQF	NYNRIN	1671	Q9P2P1
PTNESLQEEWIPFRR	PAFAH2	156	Q99487
QEILVNWDPPVRTNG	USH2A	4546	O75445
RPVEALFQLWTAEPL	RNPEPL1	531	Q9HAU8
IWLEPEVLFSGPRQA	RPE65	401	Q16518
VPAQPGPTRWQRREE	TRIM46	471	Q7Z4K8
RVTLPGQEEPWDIRN	URM1	26	Q9BTM9
PQRWFVTPANNRLDF	TBR1	481	Q16650
QGIVPPGLTENELWR	SFXN1	56	Q9H9B4
FIQIRGSVPLFWEQP	SYNJ1	246	O43426
IRGSVPLFWEQPGLQ	SYNJ2	251	O15056
EPFLRQEGSQWRPLL	ABCC6	286	O95255
TAQNRPVQRFWPDSI	PKNOX1	336	P55347
IDVRPPLDWGPQRQT	PLEKHA4	276	Q9H4M7
LAWVPGRTPQFGQLV	TAF1C	216	Q15572
ARALPFWNEEIVPQI	PGAM2	161	P15259
QNRIWEREPAPLLSA	NCOR1	2416	O75376
EEAPGARPQLQDAWR	EPPK1	3646	P58107
EEAPGARPQLQDAWR	EPPK1	4716	P58107
PFVRWEQNRQPLLLD	NEO1	181	Q92859
DNTVRVWDVRPFAPK	SNRNP40	256	Q96DI7
QVFSELGFPPAVQRW	SHARPIN	256	Q9H0F6
RVTQEVPPGVFWRSQ	TENM2	456	Q9NT68
VRIPPWQFERKLNDS	POLR3H	11	Q9Y535
VRAFQWDPQQPRLAI	WRAP73	376	Q9P2S5
FKPTRDDRGWIINPI	SLC4A8	761	Q2Y0W8
FQEQLASELWPRARP	SRCAP	2006	Q6ZRS2
DQGPIRAWSVLPDNF	SOWAHB	321	A6NEL2
EREFWQLLRDPNTPL	TCN2	391	P20062
WTVLQGRIGRPDNPF	ALK	386	Q9UM73
IFRALGTPNNEVWPE	CDK1	216	P06493
ELQRQQSPGLGRPIW	SLC25A12	306	O75746
WFKNDAPVVQEPRRL	ROR1	91	Q01973
WQATPFRAVAEPGIQ	THBS4	821	P35443
PWVEDRERPEFQAVQ	ZNF707	66	Q96C28
RVPIWDQDIQFLPGS	WDR74	181	Q6RFH5
IGNFELLWRQPVVEP	TTLL8	576	A6PVC2
NISTPRGIPDEWRIF	ZCCHC8	371	Q6NZY4
ERERFTVQEWGPPAA	TMEM179	56	Q6ZVK1
VQELERIGWPNAPIL	VWF	1636	P04275
RIGWPNAPILIQDFE	VWF	1641	P04275
DFTVQLWPRQLLTRP	TEP1	2031	Q99973
GDQVWLFIDEPRRRP	AARS1	586	P49588
RRQVDEGVWPPPNNL	SRCIN1	826	Q9C0H9
FWRLVDSPDIQPVGT	SCML2	106	Q9UQR0
PTVENEQPSLVWFDR	SGIP1	521	Q9BQI5
AWLVRSFLPGNQEDP	PPM1M	396	Q96MI6
AWPEPRQREQQLLEF	TTC5	256	Q8N0Z6
WELNPQDRPSFTELR	AXL	786	P30530
RFLPGVLIGWENQPT	PHF3	1441	Q92576
VRQLSPEDRAFWLQP	STAB1	1031	Q9NY15
QEIPPGIFWRSQLFI	TENM3	396	Q9P273
AEEPVPQAGQELRVW	NAPRT	441	Q6XQN6
PLQPQAPRREITGWD	ARHGAP31	986	Q2M1Z3
QLRRAQAVDELDWPP	REM2	76	Q8IYK8
PDQVRLLWTDPRNVG	THBS3	856	P49746
INQPVAFVRRIPWTA	SLIRP	16	Q9GZT3
QWLQEERVPRQRSPY	SEC16B	131	Q96JE7
EIQAWVRGQRPGSPE	ZNF446	81	Q9NWS9
QGAEPWIVEETPNLR	ZNF717	76	Q9BY31
PEQLQLRIAFWSFPE	ZSWIM8	101	A7E2V4
QTPWPAQPQRTFRDI	TMEM245	856	Q9H330
RFQVWFQANLPGVLP	TTC12	416	Q9H892
RQVVRDNPDFWGPLA	YIPF4	106	Q9BSR8
FQRPPISSWGGNRIL	ZNF589	171	Q86UQ0
WLENQDPREVGPLRL	TIGD5	601	Q53EQ6
NFWILRLPPGSNGEV	ZNF777	266	Q9ULD5
FNQPLTPVFWLLEGR	TRIM65	481	Q6PJ69
EPPRFLEAFGRLWQV	UHMK1	11	Q8TAS1
QPDAPLWVRFQAVRG	WDR81	791	Q562E7
QLRGQTDLPPWVLRD	WWC3	1001	Q9ULE0
RSVQDGEPWRDVPNN	TRIM58	311	Q8NG06
WLRRPLGEDNQPETQ	TLE6	131	Q9H808
RRPLVTADIQWPNGI	VLDLR	591	P98155
IGIPEPRVQIWFQNE	DUX4L2	56	P0CJ85
PLGPQLEQLDRGFWE	LIMK1	616	P53667
FPDRRVWQTVSPVEG	MXRA5	1986	Q9NR99
NITVFVPQWRTRRDP	N4BP1	656	O75113
NGVRAEPPTWLELQA	MYO7B	1176	Q6PIF6